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ABSTRACT 
Matthew Alexander Stiegel: An Exposure Study Linking Environmental and Human Biological 
Parameter Measurements, with a Focus on Th1/Th2 Cytokine Expression  
(Under the direction of Michael R. Flynn and Joachim D. Pleil) 
Diesel exhaust (DE) and ozone (O3) inhalation exposures are both recognized for 
creating, or exacerbating, cardiopulmonary health effects in humans.  The U.S. Environmental 
Protection Agency (EPA) has regulations described in the National Ambient Air Quality 
Standards (NAAQS) that establish ambient standards for O3 and for some of the constituents of 
DE, including particulate matter, carbon monoxide, nitrogen oxides and sulfur oxides, but there 
are no regulations that include all components of DE emissions. While there is scientific 
evidence for exposure-related health effects from DE and O3 separately, there is little research 
investigating co-exposures to these two pollutants. To address this data gap, this dissertation 
explores the human inflammatory response as an early indicator for exposures sufficient for 
activating the immune system with a series of highly-controlled environmental chamber studies.  
Healthy human subjects were exposed to clean filtered air, DE, O3, and DE+O3 at typical 
urban air concentrations. A multiplex immunochemistry method was used to analyze the 
Th1/Th2 inflammatory cytokines: interleukins (1β, 2, 4, 5, 8, 10, 12p70 and 13), interferon-
gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) in human blood, breath and urine 
samples.  In addition, health outcome parameters for cardiopulmonary function (systolic/diastolic 
blood pressure, forced exhaled volume in 1 second, and forced vital capacity) were measured.  
The results demonstrated sufficient sensitivity for characterizing all 10 cytokines at levels of 
0.05-0.10 pg/ml with a dynamic range up to 100 ng/ml.  Specific cytokines responded to the DE-
 iv
only and O3-only exposures, and a synergistic relationship was found as a suppression (lasting as 
long as 22 hrs) of IL-5, IL-12p70, IFN-γ, and TNF-α after DE + O3 co-exposure.   Varieties of 
relationships were explored between subject meta-data and physiological (cardiopulmonary) 
observations, which demonstrated high exposure-response variability between individuals and 
that summary data can mask certain underlying relationships.  The overall results suggest that O3 
exposure is highly correlated with decreased pulmonary function, that Th1-mediated 
inflammation is a moderator between DE+O3 exposure and post-exposure blood pressure 
modifications, and that epidemiologically observed associations between environmental 
exposures and cardiopulmonary effects are mediated by inflammatory response mechanisms.
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PREFACE 
This dissertation is structured around three distinct manuscripts.  Chapter 1 provides and 
overview of the field, introduces the importance of the research, and describes the research 
objectives. Chapters 2, 3, and 4 are individual manuscripts that describe the results from the three 
main research objectives, and thus are structured as journal articles.  Chapter 5 summarizes the 
research, discusses limitations of the study, and offers directions for future research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii
TABLE OF CONTENTS 
LIST OF TABLES ........................................................................................................................ xii 
LIST OF FIGURES ..................................................................................................................... xiii 
LIST OF ABBREVIATIONS AND SYMBOLS ........................................................................ xiv 
CHAPTERS 
1. Introduction ..................................................................................................................................1 
1.1 Overview ........................................................................................................................1 
1.2 Epidemiological and Controlled Exposure Evidence for Diesel Exhaust  
and Ozone Health Effects ..............................................................................................6 
 
1.3 Inflammatory Cytokines and Health Effects ..................................................................7 
1.4 Study Design ................................................................................................................10 
1.5 Objectives ....................................................................................................................12 
2. Analysis of Inflammatory Cytokines in Human Blood, Breath Condensate,  
and Urine using a Multiplex Immunoassay Platform ........................................................15 
2.1 Introduction ..................................................................................................................15 
2.2 Methods........................................................................................................................19 
2.2.1 Sample Collection .........................................................................................19 
2.2.2 Analysis.........................................................................................................20 
2.2.3 Method Development ....................................................................................21 
2.2.4 Statistical Analysis ........................................................................................22 
2.2.4.1 Model Development.......................................................................22 
2.2.4.2 Calibration and Sensitivity .............................................................22
 ix
 
2.2.4.3 Correlations and Variance Estimates .............................................23 
2.3 Results ..........................................................................................................................26 
2.3.1 Objective 1-Detection of Cytokines in Three Biological Media ..................26 
2.3.2 Objective 2-Cytokine Methodological Parameters .......................................28 
2.3.3 Objective 3-Study Sample Cytokine Measurement  
Distributions and Correlations ......................................................................31 
2.4 Discussion ....................................................................................................................37 
2.4.1 Calibration.....................................................................................................38 
2.4.2 Sensitivity and Method Precision .................................................................38 
2.4.3 Study Sample Cytokine Measurement  
Distributions and Correlations ......................................................................39 
2.5 Conclusions ..................................................................................................................42 
3. Diesel Exhaust and Ozone Inhalation Exposures affect Inflammatory Cytokine  
            Levels and White Blood Cell Counts.................................................................................43 
3.1 Introduction ..................................................................................................................43 
3.2 Methods........................................................................................................................48 
3.2.1 Study Population ...........................................................................................48 
3.2.2 Exposure Scenario: Highly-controlled Environmental Chamber .................48 
3.2.3 Sample Collection and Analysis ...................................................................49 
3.2.4 Statistical Analysis ........................................................................................50 
3.3 Results ..........................................................................................................................51 
3.3.1 Descriptive Statistics for the Four Exposures ...............................................51 
3.3.2 Exposure Responses - Pre vs. Post vs. Follow-up ........................................55 
3.3.3 TNF-α ............................................................................................................59 
 x
3.3.4 Cellular Response and Correlations with Cytokines ....................................61 
3.4 Discussion ....................................................................................................................65 
3.4.1 Pre, Post, and Follow-up Trends ...................................................................67 
3.4.2 TNF-α ............................................................................................................68 
3.4.3 White Blood Cells and Correlations .............................................................70 
3.5 Conclusions ..................................................................................................................72 
4. Co-exposure to Diesel and Ozone Modifies Inflammatory Cytokine Expression,  
Blood Pressure, and Lung Function ...................................................................................74 
4.1 Introduction ..................................................................................................................74 
4.2 Methods........................................................................................................................76 
4.2.1 Study Design .................................................................................................76 
4.2.2 Statistical Analysis ........................................................................................77 
4.3 Results ..........................................................................................................................78 
4.3.1 Summary Statistics........................................................................................78 
4.3.2 Correlations ...................................................................................................82 
4.3.3 Comparisons of Percent Change from Baseline ...........................................87 
4.4 Discussion ....................................................................................................................90 
4.5 Conclusions ..................................................................................................................94 
5. Concluding Remarks and Observations .....................................................................................96 
5.1 Cytokine Methods Development .................................................................................98 
 5.2 Inflammatory Response Following Diesel Exhaust and  
                  Ozone Exposures .......................................................................................................100 
 5.3 Correlations between Diesel and Ozone Co-exposure and  
                  Cardiovascular Health ................................................................................................101 
5.4 Limitations .................................................................................................................103 
 xi
5.5 Future Work ...............................................................................................................105 
5.6 Conclusions ................................................................................................................106 
REFERENCES ............................................................................................................................107 
 
 
 
 
 
 
 xii
LIST OF TABLES 
Table 2.1 - Comparison of the Percentage of Samples above the nominal  
LLOQs between the Original Output and the “New” 5pl Model ...............................27 
Table 2.2 - Estimated 95% Fold-Ranges (Y ෠ܴ0.95c) and Intraclass Correlation  
Coefficients ሺρො௖ሻ for repeated measures of spiked calibration samples ....................29 
Table 2.3 - Descriptive Statistics and Estimated Fold-Ranges for Duplicate  
Samples ......................................................................................................................30 
Table 2.4 - Descriptive Statistics (pg/mL) for Cytokines in Plasma .............................................31 
Table 2.5 - Descriptive Statistics (pg/mL) for Cytokines in Exhaled Breath  
Condensate .................................................................................................................31 
Table 2.6 - Descriptive Statistics (pg/mL) for Cytokines in Urine ...............................................32 
Table 2.7 - Estimated Variance Components, Fold-ranges, and ICCs  
for the Study Samples .................................................................................................34 
Table 3.1 - Demographics of Study Participants for Selected Samples ........................................48 
Table 3.2 - Descriptive Statistics by Exposure, for Plasma ..........................................................54 
Table 3.3 - Cell Count Descriptive Statistics by Exposure and Sample Time ..............................62 
Table 3.4 - Pre, Post, and Follow-up Statistical Comparisons by Exposure .................................63 
Table 4.1 - Demographics of Study Participants...........................................................................76 
Table 4.2 - Baseline and Post-Exposure Blood Pressure and Lung Function  
Measurements .............................................................................................................79 
Table 4.3 - Summary of Statistically Significant Day 1 Pre-to-Post Exposure  
Results for Selected Cytokines ...................................................................................81 
Table 4.4 - Estimated Intraclass Correlation Coefficients ሺρො௛ሻ for the Four Exposures ..............83 
Table 4.5 - Individual Responses by Exposure in Comparison to the Clean Arm ........................84 
Table 4.6 - Statistically Significant Correlations between Blood Pressure,  
FEV1, FVC, and Cytokines, by Exposure ...................................................................85 
 
 
 xiii
LIST OF FIGURES 
Figure 1.1 - Ultra-fine Particulate Exposure and Causal Pathways for  
Cardiovascular-related Health Effects ........................................................................8 
Figure 2.1 - IL-8 Calibration Curve for Urine Displaying the Additional  
Sample Concentrations Gained from using a 5pl Model ..........................................28 
Figure 2.2 - Cytokine Correlations (Spearman “Rho”) between Blood Plasma  
and Exhaled Breath Condensate ...............................................................................37   
Figure 3.1 - Exposure Schedule for Volunteers ............................................................................49 
Figure 3.2 - Heatmap of the Plasma Cytokine Levels for All Exposure  
Treatments over a 24-hour Period.............................................................................52 
Figure 3.3 - Post/Pre Exposure Cytokine Concentration Ratios  
for the Four Treatments ............................................................................................55 
Figure 3.4 - Follow-up/Pre Exposure Cytokine Concentration Ratios  
for the Four Treatments ............................................................................................56 
Figure 3.5 - TNF-α Cytokine Results for Three Exposure Scenarios ...........................................60 
Figure 3.6 - Spearman Correlations for Pre, Post and 22-hour Post DE+O3  
Co-Exposure Responses............................................................................................64 
Figure 4.1 - Post/Pre DE+O3 Exposure Ratios for Blood Pressure, FEV1, FVC,  
and Th1/Th2 Inflammatory Cytokines......................................................................82 
Figure 4.2 - Systolic Blood Pressure Post/Pre Exposure Ratio versus IL-8  
Post/Pre Exposure Ratio for the DE+O3 Exposure ...................................................86 
Figure 4.3 - Systolic Blood Pressure Post/Pre Exposure Ratio versus IFN-γ  
Post/Pre Exposure Ratio for the DE+O3 Exposure ...................................................87 
Figure 4.4 - Percent Change from “Pre” Measurement following O3 Exposure ..........................88 
Figure 4.5 - Percent Change from “Pre” Measurement following DE+O3 Exposure ...................89 
Figure 5.1 – Differential Lung Function Results for Four Individual Participants Following 
DE+O3 Co-exposure ...............................................................................................104 
 
 
 
 xiv
LIST OF ABBREVIATIONS AND SYMBOLS 
Abs  absolute 
ADME  absorption, distribution, metabolism, and excretion 
ANOVA analysis of variance  
AOP  adverse outcome pathway 
b  random effect 
B  biological media 
BALF  bronchoaveolar lavage fluid 
BP  blood pressure 
BMI  body mass index 
c  concentration 
oC   degrees centigrade 
CDC   Centers for Disease Control and Prevention  
COPD   chronic obstructive pulmonary disease  
CV  coefficient of variation 
CXCL2 chemokine ligand 2 
DALYs disability-adjusted life years 
DBP  diastolic blood pressure 
DE  diesel exhaust 
DE+O3 diesel exhaust plus ozone 
DEP   diesel exhaust particulate  
DEPOZ Cardiopulmonary Responses to Exposure to Ozone and Diesel  
Exhaust with Moderate Exercise in Healthy Adults 
 
DNA  Deoxyribonucleic acid 
 xv
ε  random-error effect 
EDTA  Ethylenediaminetetraacetic acid 
EPA   Environmental Protection Agency 
EBC  exhaled breath condensate 
FEV1  forced exhaled volume in one second 
FR  fold-range 
FVC  forced vital capacity 
GM  geometric mean 
GSD  geometric standard deviation 
GSTM1 glutathione S-transferase mu 1 
h  biological measurement 
Hg  mercury (element) 
HSF  Human Studies Facility 
i  plate 
ICC  intra-class correlation coefficient 
IFN-γ  interferon gamma 
IL  interleukin 
IL-1B  interleukin 1 beta 
IL-2  interleukin 2  
IL-4  interleukin 4 
IL-5  interleukin 5 
IL-8  interleukin 8 
IL-10  interleukin 10 
 xvi
IL-12p70 interleukin 12p70 
IL-13  interleukin 13 
IRB   Institutional Review Board 
ln  natural logarithm 
LOD  limit of detection 
LOQ   limit of quantitation 
L/min  liters per minute 
LLOQ  lower limit of quantitation 
Lymph  lymphocyte 
MSD  Mesoscale Discovery 
MTBE  methyl tertiary butyl ether 
mg  milligram(s) 
ml  milliliter(s) 
mm  millimeter(s) 
Mono  monocyte 
n  number 
NAAQS  National Ambient Air Quality Standards 
NIOSH National Institute of Occupational Safety and Health  
ng  nanogram(s) 
ng/ml  nanogram per milliliter 
NSAIDs non-steroidal anti-inflammatory drugs 
NO  nitrogen oxide 
NO2  nitrogen dioxide 
 xvii
NOx  oxides of nitrogen 
O3  ozone  
PM  particulate matter 
PM2.5  particulate matter less than 2.5 microns diameter  
PM10  particulate matter less than10 microns diameter 
ppm  parts per million 
pg  picogram(s) 
pg/ml  picogram per milliliter 
pg/m3  picogram per cubic meter 
PMN  polymorphonuclear neutrophils 
Proc  procedure 
PGF2α  Prostaglandin F2α 
ρ  rho 
ߩො  estimated intraclass correlation coefficient 
෠ܴ0.95  estimated 95% fold-range 
rpm  rotations per minute 
SBP  systolic blood pressure 
SD  standard deviation 
SE  standard error  
SEM  standard error of the mean 
SO2  sulfur dioxide 
ߪො௕௒ଶ   estimated total between-person variance 
ߪො௪௒ଶ   estimated total within-person variance 
 xviii
TCE  trichloroethylene 
Th1  T helper cell 1 
Th2  T helper cell 2 
TNF-α  tumor necrosis factor alpha 
TWA  time weighted average 
UFP  ultra-fine particulate 
US  United States 
µ  mean 
µL  microliter 
μg/m3  microgram per cubic meter 
µm  microns 
WBC  white blood cells 
WHO  World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 1
CHAPTER 1 
Introduction 
1.1 Overview 
The World Health Organization estimates that outdoor air pollution contributes to the 
deaths of 3.7 million people each year in the world, with approximately 40,600 deaths per year 
and 11.4 million disability-adjusted life years (DALYs) lost in the United States (US) due to 
asthma, cardiovascular disease, and chronic obstructive pulmonary disease (COPD) (CDC, 2002; 
CDC, 2011a and 2011b; WHO, 2009; WHO, 2014).  In the US, the relative risk of death 
attributable to outdoor air pollution exposures is comparatively low, but air pollution is usually 
concentrated in large urban areas with dense populations and thus the exposure potential to 
outdoor air pollution remains relatively high (Dockery et al., 1993; Ghio and Huang, 2004).  
Outdoor inhalation exposures to particulate matter (PM) and ozone (O3) are driving causes of 
environmentally acquired disease and mortality (Bell et al., 2005; Dockery et al., 1993; Huang 
2014; Jerrett et al., 2009; Knol et al., 2009).  Acute PM exposures have been shown to 
exacerbate existing asthmatic conditions and COPD and contribute to decreases in lung function 
(Huang and Ghio, 2009; Ghio and Huang, 2004; Lepeule et al., 2012; Pope and Dockery, 2006).  
Chronic exposures to PM have been shown to cause acute lower respiratory disease, ischemic 
heart disease, and lung cancer (Ghio and Huang, 2004; Montesano and Hall, 2001; Pope and 
Dockery, 2006).  Long-term effects of O3 exposure have not been as extensively studied as PM, 
but acute O3 exposures have been shown to cause an increase in cardiopulmonary-related 
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emergency room admissions, respiratory morbidity and mortality (Alexeeff et al., 2008; Bell et 
al., 2004; Huang 2014; Jia et al., 2011; Samoli et al., 2009).   
The United States Environmental Protection Agency (US EPA) has regulations in the 
National Ambient Air Quality Standards (NAAQS) for coarse (PM10) PM, fine (PM2.5) PM, and 
ground level O3, which are designed to protect human health (Clean Air Act, 1963).  The US 
EPA estimates that 23% of PM2.5 in the US comes from diesel exhaust (DE) emissions; however, 
there are no NAAQS for all of the components of DE (U.S. EPA, 2002). NAAQS does establish 
emission criteria for some of the constituents of DE, including particulate matter, carbon 
monoxide, nitrogen oxides and sulfur oxides, but the mixture of components is not regulated.  
The US EPA does regulate in production diesel engine emissions related to PM and NOx (U.S. 
EPA, 1997).  Current estimates show that there at least 26 million people in the US with asthma, 
15 million with COPD, and approximately 24 million with impaired lung function (CDC, 2002; 
CDC, 2011a and 2011b;).  Given a large population with diagnosed cardiovascular impairments 
as well as other susceptible sub-populations, and the potential for continued exposure-related 
health effects even with the current NAAQS, research into the underlying exposure-response 
biological mechanisms responsible for the initiation or progression of DE-related health effects is 
pertinent (Brook, 2008; Fariss et al., 2013; Huang, 2014; Kamal et al., 2009). 
 There is scientific evidence for exposure-related health effects from DE and O3, but there 
is little research investigating co-exposure to these two pollutants.  Investigating a DE+O3 co-
exposure is potentially more important than a DE-only or O3-only exposure because an 
environmental exposure to a mixture of pollutants is a more likely scenario than an exposure to 
an individual pollutant.  There are multiple ways to investigate potential health effects from a 
DE+O3 exposure including: in vitro studies, in vivo human and non-human animal studies, in 
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silico computational methods, and cross-sectional or observational epidemiological studies.  
Each of these study designs has its respective benefits toward defining exposure and subsequent 
risk.  Most often, the benefit is the ability to have high throughput risk analysis for as many 
chemicals as possible, which is often an area where the use of human test subjects is very 
difficult and sometimes unethical.  However, the main limitation for most of these study designs, 
particularly in vitro and non-human in vivo studies, is the ability to investigate individual 
responses to an exposure.  Nevertheless, the goal of each study type is to link the exposure 
source to an environmental measure, through the ADME (absorption, distribution, metabolism, 
and excretion) process, and to biologically relevant outcome parameter(s). 
Assigning risk for a DE+O3 co-exposure involves the creation of a link from the exposure 
to a health outcome with exposure, kinetic, or statistical models that assign exposure, dose, or 
biologically relevant dose.  Measurements (i.e. empirical data) are needed to create and validate 
these models but the state of the science often lacks a clear link from an exposure source to a 
health outcome based on unambiguous empirical evidence.  There are many difficulties in 
making said measurements, determining the degree to which a person has been exposed to a 
contaminant of concern, and then trying to link this exposure to a health outcome.  Each 
individual also has their own “exposome”, which is defined as the “representation of the totality 
of all exposures” that a person might receive in their lifetime and includes exposure to 
exogenous chemicals as well as endogenously-produced toxicants (Wild, 2005; Rappaport and 
Smith, 2010).  Variance in an individual’s exposome comes from the level of the exposure, the 
almost certain exposure to a chemical “mixture” instead of an individual chemical, genetic 
and/or metabolic differences between people, the route of the exposure, and the physical/social 
characteristics associated with a person (age, ethnicity, health status, body mass index, socio-
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economic status, etc.).   Given the obvious sources of variance that can contribute to differing 
biological responses, limiting potential exposure variance is the easiest way to examine how an 
individual will respond.  As such, highly-controlled environmental exposure chambers are used 
as a potential solution, which creates a uniform exposure potential and thus exposure-response 
differences can be attributed to the individual.  The present study uses a highly-controlled 
exposure scenario to investigate the relationship between DE, O3, and DE+O3 co-exposures and 
the resulting responses in human volunteers.   
Understanding the underlying biological exposure-response mechanisms following the 
exposure is also important because it can help to describe the biological pathway that contributes 
to adverse outcomes (Ankley et al., 2010; Vinken, 2013).  Scientific evidence demonstrates that 
an inflammatory response by the immune system is one of the first biological responses 
following exposure (Duramad et al., 2007; Elvidge et al., 2013; Goldsby et al., 2000; Hetland et 
al., 2004; Nakamura et al., 2014; Selgrade et al., 2006; Spatari et al., 2013;).  A large diversity of 
immune system cells respond during an inflammatory reaction and cytokines are used as 
communication vehicles between these cells.  Research shows that inflammatory cytokines are 
associated with DE and O3 exposure-response mechanisms and independently with human 
disease and health endpoints (Bosson et al., 2008; Chuang et al., 2007; De Prins et al., 2014; 
McCreanor et al., 2007; Mills et al., 2005; Villeneuve et al., 2011; Xu et al., 2013).  However, 
the studies that have established the relationships between inflammatory cytokines and disease 
have usually focused on small and select representative populations that are already categorized 
as “unhealthy”.   Given that there is scientific, biological linkage between inflammatory 
cytokines and disease, it is important to investigate how these biomarkers vary with 
environmental exposure to DE, O3, and DE+O3. 
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The overall objective of this dissertation is to describe the relationships that DE, O3, and 
DE+O3 exposures have with the human inflammatory pathway and resulting cardiopulmonary 
health effects.  Inflammation is used not only as a parameter to describe the exposure-response-
health effect relationship, but also as a parameter that links the exposure to a biological pathway 
that is associated with disease.  While the exposure levels in this study are not going to induce 
disease, studying the relationship between these exposures and potential preclinical health effects 
are essential for assigning associated risk, especially for identifying susceptible sub-populations.  
This research study is organized around three objectives: 
1. Develop and optimize a human Th1/Th2 Cytokine 10-Plex immunoassay and then apply 
this method to generate measurement distributions of inflammatory proteins in a group of 
human cohorts.   
2. Determine the difference in inflammatory cytokine expression for clean filtered air, DE 
(300 μg/m3), O3 (0.3 ppm), and a DE+O3 co-exposure under the following hypotheses:  
a. There will be no change in the expression of the cytokines for the control (i.e. 
clean) exposure; however, there will be some statistically significant increases in 
the expression of the pro-inflammatory cytokines for the other three (DE, O3, and 
DE+O3) exposures. 
b.The anti-inflammatory cytokines will show no change in expression for any of the 
four treatments. 
3. Determine whether inflammatory cytokine expression can be an indicator of a 
cardiopulmonary health outcome following exposure to the DE, O3, or DE+O3 exposure 
under the following hypotheses: 
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a. Inflammatory cytokines can be used as quantitative markers of inflammation and 
possible indicators of cardiopulmonary health effects. 
b. The relationship among three exposures will demonstrate individual variance in 
responses for both the cytokines and the health outcomes. 
 
1.2 Epidemiological and Controlled Exposure Evidence for Diesel Exhaust and Ozone 
Health Effects 
 
Numerous epidemiological studies have shown that DE and O3 exposures are related to 
cardiopulmonary health effects (Dong et al., 2013).  The primary concern for DE exposure 
comes from the much-studied inhalation effects of PM2.5 or ultrafine PM (≤0.1μm) due to the 
ability of the PM to deposit in the deep lung (Elvidge et al., 2013; Sydbom et al., 2001).  
Dockery et al., 1993, in the Harvard Six Cities prospective cohort study, were one of the seminal 
groups that defined strong associations between fine particulate and increased mortality.  
Nineteen years later, and after the establishment of more stringent PM regulations, Lepeule et al., 
2012 showed a linear exposure-response relationship between increases in PM2.5 and increases in 
cardiovascular and lung cancer mortality from additional years (2001-2009) of Harvard Six 
Cities data.  Epidemiological studies for O3-related health effects from ambient exposures have 
shown decreases in lung function, changes in heart rate variability, and vascular inflammation 
(Alexeeff et al., 2008; Bell et al., 2004; Jerrett et al., 2009; Jia et al., 2011).     
In addition to epidemiological research, there are human-based controlled chamber 
studies that examine DE exposure, with a primary focus on the relationship between acute 
cardiovascular effects and the PM component of the exposure.  These controlled DE exposures 
have demonstrated vascular impairment, blood pressure modifications, and allergic inflammation 
following exposure (Holgate et al., 2003; Mills et al., 2005; Törnqvist et al., 2007; Xu et al., 
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2013).  More recently, Morishita et al., 2014, showed an association between exposure to PM2.5-
10 and modifications in systolic blood pressure for healthy human volunteers following a 
controlled exposure.  Controlled O3 exposures with healthy human volunteers demonstrate health 
effects similar to DE exposure with increases in pulmonary and vascular inflammation and 
decreases in lung function (Alexis et al., 2010; Devlin et al., 2012; Kim et al., 2011).  Finally, 
Madden et al. 2014, showed decreases in lung function though a controlled O3 exposure, but no 
health effects following controlled exposure to DE.  This same study also established a 
relationship between DE and O3 by using controlled DE+O3 co-exposures that demonstrated a 
synergistic effect on lung function changes following the combined exposure versus individual 
exposure to DE or O3.  
 
1.3 Inflammatory Cytokines and Health Effects 
 The biological mechanisms that create acute or chronic health effects following DE or O3 
exposure are still not well understood; however, there are multiple hypotheses for the initiating 
mechanism that lead to downstream cardiopulmonary health effects.  The majority of the DE 
exposure literature focuses on the particulate component of the exhaust as the initial stressor 
(Bosson et al., 2008; Holgate et al., 2003; Shan et al 2014; Törnqvist et al., 2007; Xu et al., 
2013).  Figure 1, below, describes the three most plausible mechanistic pathways for 
cardiovascular health events following ultrafine particulate (UFP) exposure (Knol et al., 2009).  
The PM size distribution of DE varies based the source so the presented pathways might not be 
representative of all DE exposures.  However, there is consensus that DE exposure either causes 
an initial pulmonary inflammatory reaction (Arm “A”) or less likely, the PM passes through the 
alveolar-capillary barrier after deposition in the lung tissue and into the circulatory system (Arm 
“B”) (Frampton et al., 2013; Ghio and Huang, 2004; Knol et al., 2009). 
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Figure 1.1: Ultra-fine particulate exposure and causal pathways for cardiovascular-related health 
effects*  
 
*from Knol et al., 2009. 
Inflammation is also the driving cause for O3-related cardiopulmonary health effects (Alexis et 
al., 2010; Devlin et al., 2012; Koren et al., 1989; Tank et al., 2011).  Given the potential for both 
DE and O3 to create an inflammatory reaction, investigating biomarkers related to inflammation 
could elucidate the mechanistic pathway(s) that link said exposures to cardiovascular outcomes.  
Thus, we chose a select group of inflammatory proteins (cytokines) and examined their 
expression and response as a mediator between the exposures and cardiopulmonary health 
outcomes.    
Cytokines are intercellular signaling proteins that play an important role in the innate and 
the adaptive human immune response to stressors.  They have a vast range of responsibilities, 
including: recruitment of cells of the immune systems in response to an exogenous/endogenous 
antigen, cell growth and differentiation, and initiating or suppressing an inflammatory response 
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(Chung and Barnes, 1999; Goldsby et al., 2000).  Unlike hormones, which are loosely 
categorized into the other class of signaling molecules in the body and primarily work in an 
endocrine fashion, cytokines usually behave in a paracrine manner and are rarely stored, 
meaning that their expression is exclusively linked as a response to specific stimuli.  The 
cytokines chosen for this study are responsible for initiating (IL-1β, IL-2, IL-8, IL-12p70, IFN- 
γ, and TNF- α) or suppressing (IL-4, IL-5, IL-10, IL-13) an inflammatory reaction, and primarily 
originate from T helper cell Type 1 (Th1), T helper cell Type 2 (Th2), and macrophages 
(Boonpiyathad et al., 2013; Cannas et al., 2010, Chung and Barnes, 1999; Cousins et al., 2002; 
Elenkov and Chrousos, 1999; Goldsby et al., 2000; Sack et al., 2006).  
 Researchers have investigated the relationships between cytokine expression and DE or 
O3 exposures as well as cytokine expression and health effects, but these two research aims 
(exposure to inflammation, inflammation to health effect) are often mutually exclusive of one 
another.  There are no studies that investigate an inflammatory response following controlled 
DE+O3 exposure in humans.  De Prins et al. 2014, demonstrated that black carbon (a component 
of DE) exposure is associated with oxidative stress and increases in IL-1B.  Holgate et al. 2003, 
demonstrated increased IL-8 concentrations following a controlled 2-hour DE chamber study.  
Törnqvist et al. 2007, found statistically significant increases in IL-6 and TNF-α after DE 
exposure. Finally, Xu et al. 2013, studied healthy volunteers exposed to DE and saw no change 
in inflammatory cytokines, but they did see a significant increase in peripheral blood monocyte 
and leukocyte counts. 
There is also scientific evidence linking O3 exposure to changes in inflammatory 
biomarker levels.  Alexis et al. 2010, found significant increases in sputum-acquired cytokines 
(IL-6, IL-8, IL-12p70, and TNF-α) as well as increases in neutrophils and dendritic cells in 
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health human volunteers exposed to O3.  Devlin et al. 2012, also showed statistically significant 
increases in IL-1β, IL-8, TNF-α, and neutrophils in healthy human volunteers following O3 
exposure.  Schelegle et al. 1989, investigated acute ozone exposures (0.20ppm and 0.35ppm for 
80 minutes) on O3-sensitive and non-sensitive human volunteers and found statistically 
significant increases in Prostaglandin F2α (PGF2α) in the O3-sensitive cohort following exposure.  
There is less chamber-based research investigating relationships between O3 exposure and 
inflammation when compared to the DE exposure literature.  However, the studies that do 
investigate O3 exposure are always near or below the NAAQS standard (0.075ppm, 8-hour 
TWA) for O3 exposure, and they still demonstrate statistically significant exposure-response 
inflammation in healthy humans. 
      
1.4 Study Design 
The data for this dissertation was derived from the “Cardiopulmonary Responses to 
Exposure to Ozone and Diesel Exhaust with Moderate Exercise in Healthy Adults” (DEPOZ) 
study at the U.S. EPA Human Studies Facility in Chapel Hill, NC.  DEPOZ was a “proof of 
concept” random crossover double-blind exposure design that was used to investigate the 
relationship between DE exposure, O3 exposure, a DE+O3 combination, inflammatory cytokines, 
and cardiovascular health effects.  The participants received informed consent, were trained in 
the necessary study protocols, and had medical monitoring during all exposure arms. The study 
protocol and procedures to obtain informed consent from the adult participants followed the 
guidelines set forth by the Scientific and Ethical Approaches for Observational Exposure Studies 
report and were reviewed and approved by the EPA’s Human Subjects Approving Official and 
the University of North Carolina’s Institutional Review Board (IRB study #: 09-1344). 
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  Fifteen participants were recruited for the study, with eligibility based on the following: 
18-55 years old, nominally healthy, have to be able to exercise for four 15-minute increments on 
a recumbent bike at a target minute ventilation rate of 25 L/min*body surface area, non-smoking, 
and had to be willing to discontinue use of non-steroidal anti-inflammatory drugs (NSAIDs), 
vitamin C, and vitamin E.  Further description of the protocol can be seen in Madden et al. 2014.  
Each participant was exposed in an environmentally controlled exposure chamber to clean 
filtered air, DE (300 μg/m3), O3 (0.3 ppm), or a combination of DE and O3.  The chosen exposure 
concentrations for DE and O3 were based on ambient outdoor air concentrations, occupational 
environmental exposure levels, and the demonstrated safety of these concentrations in healthy 
adults from prior studies.  The environmental exposure order was random, meaning that the 
participant started the study in any of the four exposure arms, but the second day of exposure 
was always O3.  
Five blood samples were collected per subject per exposure arm, in 10mL Vacutainer® 
(Becton, Dickinson and Company, Franklin Lakes, New Jersey) collection tubes containing 
EDTA.  The tubes were centrifuged at ≥1300 RCF, and the separated blood fractions were 
aliquotted into individual 2mL polypropylene-vials (Corning Incorporated, Corning, NY), and 
then frozen at ≤-80°C until analysis. 
Exhaled breath condensate samples were collected using a RTubeTM (Respiratory 
Research, Inc., Austin Texas) exhaled breath condensate collector.  The collector was inserted 
into an insulated sleeve containing dry ice.  Ten-minute samples were taken before and after each 
chamber exposure, for five samples per exposure arm per participant.  The RTube was removed 
from the sleeve after collection and allowed to thaw.  The volume of the sample was measured, 
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placed in a polypropylene-vial (Corning Incorporated, Corning, NY), and then frozen at ≤80°C 
until analysis.   
Consecutive urine voids were individually collected over a three-day period for each 
study participant in individual 1L high-density polyethylene containers (Chase Scientific Glass, 
Inc., Rockwood, TN).  An 8mL-aliquot of each sample was transferred into a 10ml 
polypropylene vial (Corning Incorporated, Corning, NY) and immediately frozen at ≤-20°C as 
they were received at the EPA Humans Studies Facility. 
The primary health outcomes of interest to this study were inflammatory and 
cardiopulmonary related.  As such, for each 2-hour exposure period each participant had minute 
ventilation and portable spirometry before, during, and after the exposure period, which were 
then used to assess pulmonary function (e.g. Forced Exhaled Volume in 1 Second (FEV1) and 
Forced Vital Capacity (FVC)).  Participants also had blood pressure measurements taken before 
and after each exposure period.   
Post-exposure processing of collected biological samples included analysis of the following: 
GSTM1 genotyping, total lymphocyte, monocyte, and neutrophil counts, and the Th1/Th2 
cytokines (interleukins (1β, 2, 4, 5, 8, 10, 12p70 and 13), interferon gamma (IFN- γ), and tumor 
necrosis factor alpha (TNF-α)).  The ten cytokines of interest to this study were analyzed using a 
Meso Scale Discovery (MSD, Gaithersburg, MD) Human Th1/Th2 10-plex Ultra-Sensitive 
electrochemiluminescent immunoassay and a MSD SECTOR Imager 2400. 
 
1.5 Objectives 
In summary, there is a wealth of evidence that demonstrates that DE and O3 exposures 
can influence cardiovascular health status.  Recent epidemiological studies have shown 
exposure-associated morbidity and mortality, even the current National Ambient Air Quality 
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Standards.  Controlled chamber studies have demonstrated that DE and O3 create acute 
cardiovascular effects in healthy human volunteers and that these effects might be related to an 
inflammatory response.  The GSTM1- polymorphism has also been associated with sensitivity to 
O3 exposure and decreased lung function and the increased production of cytokines in response 
to diesel particles instilled intranasally (Alexis et al., 2009; Gilliland et al., 2002; Gilliland et al., 
2004; Yang et al., 2008).  As such, examination of the exposure-response relationships by 
GSTM1 genotype as well as body mass index (BMI) and gender will help to elucidate potential 
differences in response following the respective exposures.  The motivation for this research is to 
contribute to the knowledge gaps surrounding the relationship between exposures to DE and O3 
and acute cardiovascular events, with inflammation as the mediator between the exposure and 
the health effects.  
 The research in this dissertation establishes a method for measuring 10 inflammatory 
cytokines in 3 different human-acquired biological media, which will help to explain the totality 
of the inflammatory exposure-response mechanism.  The method is then applied to human 
plasma samples from a highly-controlled chamber study to investigate individual and group-level 
responses from exposures to DE, O3, or a combination of DE+O3.  Finally, this research 
establishes correlations between the 3 exposure scenarios, inflammatory cytokines, blood 
pressure modifications, and lung function changes.  Hopefully, this research will contribute to 
future DE and O3 risk analyses, by demonstrating that even in the best case scenario (i.e. healthy 
young humans) there are notable health effects from these exposures that are driven by 
inflammation. 
This remainder of this dissertation is organized into four additional chapters.  Chapter 2 
describes the efforts to establish and verify an analytical method with an appropriate sensitivity 
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for investigating the inflammatory markers in exhaled breath condensate, plasma, and urine.  
Chapter 3 examines the relationship between the DE, O3, and DE+O3 exposures and the resulting 
inflammatory responses.  Chapter 4 examines the relationships between the exposures, the 
resulting inflammation, and connections to measured cardiovascular health effects.  Lastly, 
Chapter 5 discusses the conclusions from this research study, limitations, and directions for 
future research. 
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CHAPTER 2 
 
Analysis of Inflammatory Cytokines in Human Blood, Breath Condensate, and Urine Using 
a Multiplex Immunoassay Platform 
 
(Stiegel MA, Pleil JD, Sobus JR, Morgan MK, and Madden MC. Analysis of inflammatory 
cytokines in human blood, breath condensate, and urine using a multiplex immunoassay 
platform. Biomarkers. 2014, in review.)  
 
2.1 Introduction 
 
Random intermittent environmental exposures or chronic low-level exposures can 
produce subtle biological responses in humans that are generally difficult to quantify due to the 
complexity of biological matrices and the variability in responses to environmental exposures 
within and between individuals (Pleil, 2009; Pleil and Sobus, 2013).  Observation of such 
responses or perturbations in humans, however, is necessary to provide direct empirical evidence 
of the initiation or progression of an adverse outcome pathway (AOP) (Ankley et al., 2010; 
Vinken, 2013; Pleil and Sheldon, 2011).  An AOP, in the context of human environmental 
exposure and risk assessment, can be described as the process by which an exogenous 
environmental stressor interacts with a receptor at the molecular level, thus initiating a sequence 
of events that can eventually lead to an adverse health effect (Ankley et al., 2010).  
Understanding the linkages between environmental exposures and adverse health effects requires 
quantitative knowledge of exposure, the interaction of exposure and molecular targets, and the 
progression of key events along the AOP.  Biomarkers measurements are perhaps the best way to 
simultaneously evaluate each of these events and processes, and to link in vitro experimental 
results with in vivo outcomes and systemic effects (NRC, 2012; Pleil et al., 2012; Pleil, 2012). 
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Therefore, the discovery and identification of meaningful biomarkers and appropriate analytical 
methodologies for quantifying these biomarkers in targeted studies are important for 
understanding exposure-health effect linkages (Pleil and Stiegel, 2013).  
The human inflammatory response has been studied in detail as an initial biological 
response to all types of external influences, including physical injury, psychological stress, 
environmental chemicals, bacteria, and viruses, and thus plays an important part in exposure-
response mechanisms or AOPs (Koh et al., 2008; Dybing et al., 2004; Duramad et al., 2007; 
Selgrade et al., 2006; Spatari et al., 2013; Nakamura et al., 2014).  Scientific evidence suggests 
that inflammation has been directly associated with a large number of adverse health outcomes, 
including cancer, cardiovascular disease, and autoimmune disease (Elenkov and Chrousos, 1999; 
Murase et al., 2013; Campbell, 2004; Kampa and Castanas, 2008; Goldbergova et al., 2012).  
Furthermore, research has shown that inflammation related to environmental exposures can 
create or exacerbate cardiopulmonary health effects such as asthma and chronic obstructive 
pulmonary disease (COPD) (Devlin et al., 2012; Devlin et al., 1991; Salvi et al., 1999; Pope et 
al., 2004).  To date, most studies of inflammatory responses to environmental exposure focus on 
human populations that are already considered “unhealthy” or “at risk” so ultra-sensitive 
methods for quantifying inflammation have been considered unnecessary.      
Current in vitro and in vivo research investigating links between inflammatory responses 
and health effects often focus on a very selective group of proteins, primarily chosen based on 
the anticipated location of the inflammatory response (Candela et al., 1998; Bonisch et al., 2012; 
Ghoniem et al., 2011; Robroeks et al., 2006).  Cytokines are a large group of intercellular 
signaling proteins that play an important role in the innate and the adaptive human immune 
response to stressors.  They have a vast range of responsibilities, including: recruitment of cells 
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of the immune systems in response to an exogenous/endogenous antigen, cell growth and 
differentiation, and initiating or suppressing an inflammatory response (Chung and Barnes, 
1999).  The majority of research into pro- and anti-inflammatory cytokines focuses on their 
expression from T helper cell Type 1 (Th1), T helper cell Type 2 (Th2), and macrophages 
(Chung and Barnes, 1999; Boonpiyathad et al., 2013; Cannas et al., 2010; Cousins et al., 2002; 
Elenkov and Chrousos, 1999; Sack et al., 2006).  Unlike hormones, which are loosely 
categorized into the other class of signaling molecules in the body, cytokines are usually 
expressed in localized areas and are rarely stored, meaning that their expression is exclusively 
linked as a response to specific stimuli.   
In the past, and still to some extent, the choice of which cytokine to study was often 
limited by methodological constraints, including: lack of specificity due to competitive antibody 
binding, time/cost constraints associated with the need to run multiple singleplex ELISAs for 
different biomarkers, and matrix interferences from the selected biological media (blood, 
cerebrospinal fluid, urine, etc.) (Elshal and McCoy, 2006; Malekzadeh et al., 2012).  The 
development of very specific antibodies and multiplex and bead-based analytical techniques 
have resolved issues with specificity but assay robustness has typically limited the use of the 
analytical technique to one biological medium (Bomert et al., 2011; Chowdhury et al., 2009; 
Tighe et al., 2013; van Bussel et al., 2013).   
In human-based health effects research, blood is considered the “gold standard” 
biological fluid of choice.  Consequently, there is considerably less knowledge of cytokine 
expression in other human biological media, especially when it pertains to environmental 
exposures.  In this study, 10 cytokines (interleukins [1β, 2, 4, 5, 8, 10, 12p70 and 13], interferon-
γ (IFN- γ), and tumor necrosis factor-α (TNF- α)) are investigated in three human biological 
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media: plasma, EBC, and urine.  These cytokines are primarily produced by Th1 cells, Th2 cells, 
and macrophages and are associated with initiating (IL-1β, IL-2, IL-8, IL-12p70, IFN- γ, and 
TNF- α) or suppressing (IL-4, IL-5, IL-10, IL-13) an inflammatory response (Chung and Barnes, 
1999).  The majority of literature values for “control” samples in case-control studies show that 
each individual cytokine, as sampled in blood, EBC, or urine, are either near or below the 
methodological limit of detection (~1-10 pg/mL) or are below this nominal value and are 
generally not reported (Sanchez Perez et al., 2006; Ostrowski et al., 1998; Jacobs et al., 2001; 
Matsunaga et al., 2006).  An analytical method that can simultaneously measure each cytokine in 
plasma, EBC, and urine with each biological media at a level of detection sensitive enough to 
address subtle biological changes clearly would enhance the prospect of successfully linking 
them to health effects.  This study uses an existing ultra-sensitive multiplex (Human Th1/Th2 
Cytokine 10-Plex Assay) kit from Meso Scale Discovery (Gaithersburg, MD) that is designed for 
human plasma/serum and applies it to blood, EBC and urine samples from a nominally healthy 
group of adult volunteers (Bastarache et al., 2014).  The work presented here is novel as it 
describes analytical methods, measurement distributions, and correlations across 10 cytokines in 
three different biological media.  All of these steps are critical for evaluating chemical 
interactions at a cellular level, resulting biological responses, and potential downstream health 
effects.  The cytokine analyses were completed in distinct phases to address the following 
objectives:   
1. Determine whether cytokine markers can be detected in human biological samples 
from nominally healthy volunteers, and whether method modifications are needed 
to improve detection?   
 
2. Examine cytokine measurement reproducibility for each biological media.  
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3. Describe cytokine measurement distributions, and investigate pairwise 
correlations within and across biological media.  
 
2.2 Methods 
 
2.2.1 Sample Collection 
 
All biological specimens were collected with informed consent from healthy human adult 
volunteers at the United States Environmental Protection Agency’s (US EPA) Human Studies 
Facility in Chapel Hill, North Carolina.  The study protocol and procedures were reviewed and 
approved by the University of North Carolina at Chapel Hill’s Institutional Review Board and 
the EPA’s Human Subjects Approving Official.  A total of 90 whole blood samples and 77 
exhaled breath condensate samples were collected from 15 adult volunteers (ages 23-37 years 
old) participating in an environmental exposure assessment study conducted at the Human 
Studies Facility in Chapel Hill, NC (IRB Study #: 09-1344).  Urine samples were also collected 
from this cohort but a limited analysis (n=18) of these samples was performed.  As such, this 
data set was supplemented with a larger and more comprehensive sample set of an earlier study 
that included 382 spot urine samples collected from 29 adult volunteers, ages 19-50 years old, in 
2009-2011 (IRB Study #: 09-0741).  The addition of these samples allowed for a more 
comprehensive investigation of the methodological parameters and distributions of cytokines in 
urine. 
Six blood samples were collected per subject, in 10mL Vacutainer® (Becton, Dickinson 
and Company, Franklin Lakes, New Jersey) collection tubes containing EDTA.  The tubes were 
centrifuged at ≥1300 RCF, and the separated blood fractions were aliquotted into individual 2mL 
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polypropylene - vials (Corning Incorporated, Corning, NY), and then frozen at ≤-80°C until 
analysis. 
Six EBC samples per subject were collected using a RTubeTM (Respiratory Research, 
Inc., Austin, Texas) exhaled breath condensate collector using the (method described in Pleil et 
al. 2008).  After collection, the volume of each sample was measured, placed in a 2mL 
polypropylene vial (Corning Incorporated, Corning, NY), and then frozen at ≤-80°C until 
analysis.   
A total of 400 spot urine samples were collected from 33 adults across the two studies.  
Consecutive urine voids were individually collected over a three-day period for each study 
participant in individual 1L high-density polyethylene containers (Chase Scientific Glass, Inc., 
Rockwood, TN).  An 8mL-aliquot of each sample was transferred into a 10ml polypropylene vial 
(Corning Incorporated, Corning, NY) and immediately frozen at ≤-20°C until analysis. 
 
2.2.2 Analysis 
 
The ten cytokines of interest to this study were analyzed using a Meso Scale Discovery 
(MSD) multiplex electrochemiluminescent immunoassay system and SECTOR Imager 2400.  
The panel, Human Th1/Th2 10-plex Ultra-Sensitive Kit, was designed by MSD to analyze the 
following human biomarkers in each well: interleukins 1β, 2, 4, 5, 8, 10, 12p70 and 13; IFN- γ; 
and TNF- α.  The analysis method is described in more detail elsewhere but briefly, it proceeded 
as follows (Meso Scale Discovery, 2012).  The 96-well plates were supplied by MSD in a 
prepared format and were ready to use without further preparation.  Reagents for the assay were 
prepared according to the given procedure in the MSD literature.  Prior to analysis, all samples 
were removed from -80°C storage, thawed in an ice bath for 30-45 minutes, and then vortexed 
for five seconds to achieve uniform consistency.   
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The calibration standards for the immunoassay were supplied in a single mix at 2500 
pg/mL and required a series of 4-fold dilutions to achieve an 8-point standard curve.  Twenty-
five uL of a proprietary diluent were added to each of the 96-well plates, and the plates were 
sealed and incubated at room temperature (approximately 22.2°C) for 30 minutes at 1000 rpm.  
Next, duplicate 25 uL aliquots of each calibration standard (a total of 16 wells) and 80 individual 
samples were then added to the plate.  The 96-well plate was sealed and incubated at room 
temperature for two hours at 1000 rpm.  Then, the plate was washed three times with a phosphate 
buffered saline-0.05% Tween (PBS-T) solution.  Twenty-five uL of a detection antibody solution 
was added into each of the 96 wells followed by sealing and incubating the plate for an 
additional two hours at 1000rpm.  The plate was washed three times with PBS-T and 150 uL of 
Read Buffer was added to each well.  Finally, the plate was analyzed on a MSD SECTOR 
Imager 2400.   
 
2.2.3 Methods Development 
 
The methods development work proceeded in three stages.  First, human blood plasma 
samples (n=13) and spiked method blanks (n=84, 12 repeated spikes at each of the 7 
concentrations) were analyzed using the existing MSD methodology.  The results from this 
analysis were a set of methodological parameter estimates (lower limit of quantitation [LLOQ], 
linear range, within- and between-plate variance, etc.) that were then used as a comparison 
dataset for the other two biological media.  LLOQs were defined as three times the standard 
deviation of the “zero” method blanks on a specific plate per each cytokine.  Each 96-well plate 
that was analyzed had a different LLOQ for the respective cytokine.  As such, the mean and 
standard error of the LLOQ were calculated for each cytokine and the % <LLOQ was then 
determined using the plate-specific LLOQ values. 
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In the second stage of our analysis, a selection of EBC (n=24) and urine (n=18) samples 
was analyzed using the existing method to determine if the immunochemistry was compatible 
between different biological media, to assure that the samples were pre-processed appropriately 
and fit into the associated concentrations of the calibration curve, and to determine if the MSD 
SECTOR Imager 2400 could identify the 10 target cytokines.  Success in this stage was 
measured by the presence or lack of cytokines in EBC and urine.  In a separate experiment, we 
analyzed an additional 77 plasma samples, 53 EBC samples, and 382 urine samples; these 
measurements were combined with those from the earlier experiment to allow a comprehensive 
statistical analysis. 
 
2.2.4 Statistical Analysis  
 
2.2.4.1 Model Development 
 
The MSD DISCOVERY WORKBENCH® analysis software was used to estimate the 
concentration data for each target cytokine.  These data are based on an internally calculated 
signal-concentration 4-paramter logistic calibration curve.  When a sample’s signal is below the 
instrument derived LLOQ the software will frequently report the signal but not a calculated 
concentration.  We developed a series of 5-parameter logistic (5pl) models for each target 
cytokine to interpret these low-end signal values (Richards, 1959).  Fitting the empirical data 
with this approach allowed us to extend the original calibration curve to make robust estimates 
between “zero” and the nominal (instrument derived) LLOQ. 
 
2.2.4.2 Calibration and Sensitivity 
 
The 5pl models were constructed for each cytokine per individual plate using the 
calibration standards from that analytical run, and then applied to the study samples on that 
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respective plate (GraphPad Prism version 6.0, GraphPad Software, La Jolla, CA).  Each LLOQ 
for a specific cytokine, in an individual analysis, was established during the model construction.  
Sample detections comparing the original calibration model to the 5pl model were also 
calculated during this stage using the initial set of 13, 24, and 18 blood, EBC, and urine samples, 
respectively.  The cytokine distribution percentiles for each biological media were estimated 
using the Proc UNIVARIATE procedure of the SAS statistical software package version 9.3 
(SAS Institute, Cary, NC, USA).   
 
2.2.4.3 Correlations and Variance Estimates 
 
An α=0.05 criterion was used as the significance level for all statistical tests.  Spearman 
correlation coefficients were calculated in GraphPad for each cytokine measured in both blood 
and EBC, but not urine, given that the majority of the urine sample-set was derived from another 
sample cohort.  Cytokine measurement distributions across all three biological media were 
evaluated via visual inspection of quantile-quantile plots and Shapiro-Wilks tests for normality 
(SAS Proc UNIVARIATE).  All data were right-skewed and were natural log-transformed prior 
to further analysis to satisfy normality assumptions.   
Two different sets of linear mixed-effect models (SAS Proc MIXED) were used to 
investigate within- and between-plate variation across the spiked calibration samples (balanced 
dataset), and within- and between-person variation across the repeated study samples (Rappaport 
and Kupper, 2008).  Given that the same sample was run multiple times on a single plate and 
multiple times on different plates, the partitioning of spiked sample variance into these two 
groupings helps determine if samples run on different plates are comparable to one another.  
More within-plate than between-plate variance shows that measurement variance can be treated 
as random error and that samples run on different plates are comparable.         
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௖ܻ௜௝ ൌ ln൫ܺ௖௜௝൯ ൌ 	ߤ௒೎ ൅ ܾ௖௜ ൅ ߝ௖௜௝                                                                                           (2.1) 
The model used for spiked samples is given in equation 2.1, where c = spiked concentration of 
0.610, 2.44, 9.80, 39.1, 156, 625, or 2500 pg/mL; i = plate 1, 2, 3, 4, 5, 6, or 7 for the cth 
concentration; j = measurement 1 or 2, on the ith plate, for the cth concentration.  Here, Xcij 
represents the concentration of a cytokine (pg/mL) from the jth measurement, on the ith plate, at 
the cth concentration, and Ycij is the natural logarithm of the measurement Xcij.  The coefficients 
ߤ௒೓, bci, and εcij represent, respectively, the true (logged) mean cytokine level at the cth 
concentration, the random effect of the ith plate at the cth concentration, and the random-error 
effect of the jth measurement, on the ith plate, at the cth concentration.  It is assumed that bci and 
εcij are independent random variables with means of 0 and variances of ߪ௕௒೎ଶ  and ߪ௪௒೎ଶ , 
representing the between- and within-plate variance, respectively, at each concentration, c. 
Duplicate study samples (n= 28, 18, and 54 duplicates for blood, EBC and urine, 
respectively) were investigated using SAS Proc NESTED to estimate the proportion of 
measurement error that could be attributed to biological matrix (i.e. blood, EBC or urine) effects; 
matrix effects were not examined using spiked samples, since spikes were prepared using a 
PBS/BSA solution.  
୆ܻ௜௝ ൌ ln൫ܺ୆௜௝൯ ൌ 	ߤ௒ా ൅ ܾ୆௜ ൅ ߝ୆௜௝        (2.2) 
 
Equation 2.2, similar to equation 2.1 but with “B” biological media instead of “c” concentration, 
was used to evaluate the study samples, specifically: B = biological media 1 (blood), 2 (EBC), or 
3 (urine); i = 1, 2, …, nB individuals for the Bth biological media; and j = 1, 2, …, nBi 
measurements of a particular cytokine from the ith individual, for the Bth biological media.  Here, 
it is assumed that bBi and εBij are independent random variables with means of 0, and ߪ௕௒ಳଶ  and 
ߪ௪௒ಳଶ  represent the between- and within-person variance, respectively, for each biological media, 
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B.  Partitioning of the variance within- and between- persons helps determine whether the 
variance across the distribution for a specific cytokine (and a specific biological media) is more 
closely related to an individual or to the group.   
Restricted maximum likelihood estimates of variance components (between- and within-
plate for spiked samples, and between- and within-person for study samples) were used to 
calculate estimated 95% fold-ranges and intraclass correlation coefficients (ICC).  Estimated 
fold-ranges ( ෠ܴ0.95) were calculated for each variance component result from the spiked 
calibration sample analysis (using Equation 2.1), duplicate study sample analysis (using 
Equation 2.2), and repeated study sample analysis (using Equation 2.3).  The fold-range 
estimates used here are a scale-independent way of comparing the central 95% of the 
measurement data, thus making it easier to compare estimates across analytes and media 
(Rappaport and Kupper, 2008). 
Y ෠ܴ଴.ଽହ௖ ൌ ݁ଷ.ଽଶටఙෝ್ೊ೎
మ ାఙෝೢೊ೎మ             (2.3) 
For the spiked calibration samples, Equation 2.3 was used, where, Y ෠ܴ଴.ଽହ௖ is the estimated overall 
95% fold-range and ߪො௕௒೎ଶ  and ߪො௪௒೎ଶ represent the estimated between- and within-plate variance 
components for each spiked concentration, c.   
w ෠ܴ଴.ଽହ஻ ൌ ݁ଷ.ଽଶටఙෝೢೊಳ
మ
            (2.4) 
For the duplicate study samples, Equation 2.4 was used, where, w ෠ܴ଴.ଽହ஻ is the estimated within 
sample 95% fold-range and ߪො௪௒ಳଶ  represents the estimated within-person variance component for 
each biological media, B.  Here, “duplicate” is defined as the same sample that was analyzed two 
different times. 
Y ෠ܴ଴.ଽହ஻ ൌ ݁ଷ.ଽଶටఙෝ್ೊಳ
మ ାఙෝೢೊಳమ             (2.5) 
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For the repeated study samples, Equation 2.5 was used, where, Y ෠ܴ଴.ଽହ஻ is the estimated overall 
95% fold-range and ߪො௕௒ಳଶ  and ߪො௪௒ಳଶ represent the estimated between- and within-person variance 
components for each biological media, B. 
Estimated ICCs (ߩොሻ were calculated for the spiked calibration samples (Equation 2.6) and 
the study samples (Equation 2.7) using the following formulas: 
ߩො௖ = ఙෝ್ೊ೎
మ
ఙෝ್ೊ೎మ ାఙෝೢೊ೎మ
          (2.6) 
 
ߩො஻ = ఙෝ್ೊಳ
మ
ఙෝ್ೊಳమ ାఙෝೢೊಳమ
         (2.7) 
MATLAB version 8.2 (R2013b, Mathworks, Natick, MA) and GraphPad were used for 
graphical representations. 
 
2.3 Results 
 
2.3.1 Objective 1-Detection of Cytokines in Three Biological Media  
 
Table 2.1 shows the percentage of individual study sample cytokine levels that are above 
the respective LLOQs using either the instrument-derived software (“Original”) or a 5pl model 
(“New).   The majority of the cytokines in each biological medium have ≥ 80% of samples that 
are above the LLOQ when using the original instrument output.  Results show increases in the 
percentage of samples above the LLOQ using the 5pl model, thus confirming that there is an 
improvement in overall system sensitivity.  The EBC samples have less of an increase in the 
percentage of samples above the LLOQ when compared to the results from the blood or urine 
samples.  Investigating this difference shows that a large percentage of the EBC samples had 
responses similar to those of the blank calibration points; this is not unexpected as EBC is a very 
dilute biological fluid.  Overall, the use of the 5pl model increased the percentage of samples 
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above the LLOQ by 9.24%, 7.92%, and 9.39% for the blood, EBC and urine samples, 
respectively.  
Table 2.1: Comparison of the Percentage of Samples above the nominal LLOQs between the 
Original Output and the “New” 5pl Model  
Blood1 EBC2 Urine3 
 Cytokine Original New Original New Original New 
IL-1β 100 100 87.5 95.8 100 100 
IL-2 92.3 100 87.5 95.8 100 100 
IL-4 69.2 100 79.2 91.7 83.9 100 
IL-5 92.3 100 79.2 83.3 83.3 100 
IL-8 100 100 83.3 100 88.9 100 
IL-10 92.3 100 87.5 87.5 94.4 100 
IL-12p70 100 100 75.0 83.3 100 100 
IL-13 69.2 100 8.30 16.7 55.6 100 
IFN-γ 92.3 100 75.0 79.2 100 100 
TNF-α 100 100 83.3 91.7 100 100 
1:n=13, 2:n=24, 3:n=18 
 
Figure 2.1 displays the total range and a “zoomed-in” view of the lower end of the calibration 
curve, highlighting the additional quantitative data gained by using the 5pl model.  The blue 
circles are calculated sample concentrations based on the original output and the red circles are 
additional sample concentrations achieved through the use of the 5pl model.  This figure is a 
typical example of the range of values for nominally healthy adult subjects.  In this specific 
example, eight additional sample concentrations were calculated based on the use of the 5pl 
model.   
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Figure 2.1: IL-8 Calibration Curve for Urine Displaying the Additional Sample Concentrations 
Gained from using a 5pl Model. 
 
 
2.3.2 Objective 2- Cytokine Methodological Parameters 
 
Overall fold-range (Y ෠ܴ0.95c) and ICC (ρො௖ሻ estimates, based on repeated measurements of 
spiked calibration samples, are given for individual cytokines in Table 2.2.  Here, the fold range 
estimates contain the central 95% of all cytokine measurements for the spiked samples at a given 
concentration level and biological media.  The ICCs display the portion of total measurement 
variance that was observed between plates.  These results were achieved using a prepared 
standard solution, and unlike blood, EBC or urine, with their associated proteins, cells, etc., 
should be indicative of a “best case” scenario where matrix-interferences play a minimal role in 
cytokine quantitation. 
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Table 2.2: Estimated 95% Fold-Ranges (Y ෠ܴ0.95c) and Intraclass Correlation Coefficients ሺρො௖ሻ for 
repeated measures of spiked calibration samples. 
  Concentration (pg/mL)a   
Cytokine 0.61 2.44 9.77 39.1 156 625 2500 Average 
IL-1β 3.77 
(0.00) 
1.52 
(0.00) 
1.20 
(0.00) 
1.10 
(0.00) 
1.33 
(0.00) 
1.23 
(0.281) 
1.40 
(0.00) 
1.65 
(0.040) 
IL-2 2.28 
(0.00) 
1.46 
(0.00) 
1.30 
(0.045) 
1.12 
(0.00) 
1.24 
(0.105) 
1.16 
(0.269) 
1.57 
(0.00) 
1.45 
(0.060) 
IL-4 3.19 
(0.00) 
1.69 
(0.195) 
1.50 
(0.044) 
1.26 
(0.00) 
1.44 
(0.230) 
1.14 
(0.100) 
1.38 
(0.00) 
1.66 
(0.081) 
IL-5 1.21 
(0.219) 
1.24 
(0.018) 
1.23 
(0.031) 
1.09 
(0.048) 
1.27 
(0.00) 
1.13 
(0.354) 
1.13 
(0.00) 
1.19 
(0.096) 
IL-8 2.08 
(0.00) 
1.37 
(0.00) 
1.28 
(0.216) 
1.11 
(0.294) 
1.31 
(0.00) 
1.16 
(0.180) 
1.34 
(0.00) 
1.38 
(0.099) 
IL-10 2.19 
(0.361) 
1.48 
(0.00) 
1.25 
(0.357) 
1.13 
(0.434) 
1.42 
(0.00) 
1.12 
(0.318) 
1.66 
(0.00) 
1.46 
(0.210) 
IL-12 p70 2.10 
(0.00) 
1.21 
(0.135) 
1.41 
(0.00) 
1.26 
(0.00) 
1.31 
(0.030) 
1.27 
(0.380) 
1.40 
(0.00) 
1.42 
(0.078) 
IL-13 5.72 
(0.00) 
3.61 
(0.00) 
1.46 
(0.132) 
1.20 
(0.211) 
1.32 
(0.042) 
1.25 
(0.285) 
1.25 
(0.00) 
2.26 
(0.096) 
INF- γ 3.53 
(0.358) 
1.32 
(0.00) 
1.19 
(0.341) 
1.15 
(0.00) 
1.35 
(0.00) 
1.17 
(0.262) 
1.31 
(0.00) 
1.57 
(0.137) 
TNF-α 2.77 
(0.225) 
1.45 
(0.00) 
1.35 
(0.370) 
1.18 
(0.410) 
1.29 
(0.00) 
1.17 
(0.151) 
1.35 
(0.00) 
1.51 
(0.165) 
Average 2.88 
(0.116) 
1.64 
(0.035) 
1.32 
(0.153) 
1.16 
(0.40) 
1.33 
(0.041) 
1.18 
(0.258) 
1.38 
(0.00) 
 
a: Y ෠ܴ0.95cሺρො௖ሻ, all parameters were estimated using natural logged cytokine concentrations. 
 
On average, the central 95% of measurements were observed within a 1.55 fold-range 
across the 10 cytokines and seven spiked concentrations.  Fold range estimates generally 
increased as the spiked concentration decreased, with the lowest spiked concentration having the 
largest overall FRs.  The average Y ෠ܴ0.95c for the 10 cytokines at 0.610pg/mL is 2.88, where the 
average fold ranges for the other six concentrations, in increasing concentration from 2.44-
2500pg/mL, are 1.64, 1.32, 1.16, 1.33, 1.18 and 1.38, respectively.   
ICC estimates of 0.00 to 0.380 suggest that the majority of measurement variance (i.e., 
62-100%) was observed within-plate rather than between-plate.  The ICC estimates do not 
display an increasing or decreasing trend across the spiked concentrations.  Furthermore, results 
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from the mixed models show indicate no significant random plate effects across all cytokines and 
concentrations (p≥0.18).  Taken together, these results confirm that the variation in 
measurements between plates can be treated as random error, and that samples analyzed across 
different plate are directly comparable.  
Table 2.3 displays mean (±standard error) and fold-range (w ෠ܴ0.95β) estimates associated 
with all duplicate measurements of cytokines in blood, EBC, and urine.   Fold-range estimates 
based on biological media measurements were similar to those of the lowest spiked 
concentration (0.610 pg/mL).  The fold range estimates ranged from 1.36 to 4.29 for blood, from 
2.12 to 4.96 for EBC, and from 0.935 to 38.7 for urine, while the lowest spiked concentration 
had fold ranges of 1.21 to 5.72.  IL-13 had the largest fold-range for the blood and EBC samples, 
while IL-4 had the largest fold-range for the urine samples.  These results were expected given 
that the majority of the sample concentrations (not shown) lie within a concentration range 
spanning from the LLOQ-1.00pg/mL for the respective cytokines.     
Table 2.3:  Descriptive Statistics and Estimated Fold-Ranges for Duplicate Samples  
  Blood EBC Urine 
μ ± SEMa w ෠ܴ0.95Bb μ ± SEMa w ෠ܴ0.95Bb μ ± SEMa w ෠ܴ0.95Bb 
IL-1β 1.51(0.515) 3.95 5.26(1.29) 2.82 1.74(0.226) 3.33 
IL-2 0.127(0.012) 2.50 0.340(0.051) 4.96 0.935(0.208) 1.97 
IL-4 0.380(0.047) 1.36 1.27(0.159) 3.39 1.54(0.046) 5.25 
IL-5 0.639(0.256) 2.03 0.106(0.0121) 2.40 0.444(0.043) 2.41 
IL-8 2.60(0.450) 1.50 3.67(2.89) 2.27 38.7(9.27) 2.10 
IL-10 1.24(0.063) 1.56 1.12(0.082) 2.12 1.83(0.325) 2.30 
IL-12 p70 0.448(0.028) 1.45 0.612(0.074) 3.35 1.20(0.032) 2.09 
IL-13 1.32(0.108) 4.29 1.38(0.163) 4.77 2.03(0.045) 1.58 
INF- γ 0.469(0.059) 1.75 0.386(0.051) 4.45 0.945(0.050) 2.28 
TNF-α 2.14(0.118) 1.82 0.433(0.058) 4.34 0.974(0.058) 1.73 
a: μ ± SEM (mean ± standard error of the mean), b: estimated within-sample fold range, parameters were estimated 
using natural logged cytokine concentrations. 
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2.3.3 Objective 3- Study Sample Cytokine Measurement Distributions and Correlations 
 
Descriptive statistics are given in Table 2.4, 2.5, and 2.6 for cytokines measured in blood 
plasma (n=90), EBC (n=77), and urine (n=400) samples, respectively; individual cytokines are 
sorted based on the percentage of samples above the LLOQ.    
Table 2.4: Descriptive Statistics (pg/mL) for Cytokines in Plasma 
Cytokine LLOQa %>LLOQ Min 5% 25% 50% 75% 95% Max 
IL-8 0.056 (0.038) 100 0.980 1.15 1.50 1.97 2.67 3.86 41.7 
TNF-α 0.064 (0.038) 100 1.06 1.29 1.44 1.73 2.49 3.73 8.77 
IL-10 0.224 (0.060) 99.0 <LLOQ 0.486 0.746 1.26 1.59 2.31 3.23 
IL-12 p70 0.197 (0.028) 95.2 <LLOQ 0.207 0.257 0.339 0.582 0.830 1.62 
IL-5 0.055 (0.038) 94.3 <LLOQ <LLOQ 0.115 0.208 0.373 0.881 20.4 
IL-4 0.228 (0.117) 81.0 <LLOQ <LLOQ 0.220 0.277 0.347 0.569 2.59 
INF- γ 0.163 (0.104) 80.1 <LLOQ <LLOQ 0.085 0.305 0.649 1.51 3.01 
IL-13 1.34 (0.845) 78.1 <LLOQ <LLOQ 0.220 1.62 2.04 2.75 4.38 
IL-2  0.087 (0.068) 78.1 <LLOQ <LLOQ 0.047 0.093 0.189 0.262 0.633 
IL-1β 0.511 (0.717) 73.3 <LLOQ <LLOQ <LLOQ 0.160 1.56 3.38 40.3 
a: mean (standard deviation) 
 
Table 2.5: Descriptive Statistics (pg/mL) for Cytokines in Exhaled Breath Condensate 
Cytokine LLOQa %>LLOQ Min 5% 25% 50% 75% 95% Max 
IL-10 0.143 (0.062) 93.5 <LLOQ <LLOQ 0.581 0.737 1.78 2.38 3.15 
IL-8 0.369 (0.115) 92.2 <LLOQ <LLOQ 0.151 0.245 0.807 2.27 222 
IL-4 0.238 (0.107) 90.9 <LLOQ <LLOQ 0.323 0.411 2.92 3.82 4.16 
IL-5 1.32 (0.365) 89.6 <LLOQ <LLOQ 0.032 0.047 0.181 0.312 0.368 
TNF-α 0.032 (0.023) 87.0 <LLOQ <LLOQ 0.075 0.120 0.804 1.27 2.53 
IFN-γ 0.035 (0.015) 81.8 <LLOQ <LLOQ 0.058 0.099 0.582 1.22 1.62 
IL-12 p70 0.172 (0.063) 72.7 <LLOQ <LLOQ <LLOQ 0.220 1.33 1.81 2.08 
IL-1β 0.666 (0.706) 71.4 <LLOQ <LLOQ <LLOQ 2.90 5.27 13.2 94.8 
IL-2 0.187 (0.126) 71.4 <LLOQ <LLOQ <LLOQ 0.061 0.659 1.06 2.31 
IL-13 0.388 (0.274) 55.8 <LLOQ <LLOQ <LLOQ 0.244 2.86 3.64 4.26 
a: mean (standard deviation) 
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Table 2.6: Descriptive Statistics (pg/mL) for Cytokines in Urine 
Cytokine LLOQa %>LLOQ Min 5% 25% 50% 75% 95% Max 
IL-2 0.161 (0.160) 96.5 <LLOQ 0.050 0.188 0.394 0.613 1.36 62.3 
IL-1β 0.177 (0.084) 95.0 <LLOQ <LLOQ 0.207 0.693 2.26 24.4 382 
IL-4 0.130 (0.053) 94.5 <LLOQ <LLOQ 0.027 0.070 0.997 3.27 3.73 
IL-8 0.116 (0.050) 93.8 <LLOQ <LLOQ 2.82 9.74 29.4 162 2270 
IL-13 0.462 (0.238) 89.0 <LLOQ <LLOQ 0.903 2.15 3.82 7.15 33.2 
IL-10 0.216 (0.101) 88.7 <LLOQ <LLOQ 0.125 0.379 1.77 3.63 141 
IFN-γ 0.317 (0.254) 85.0 <LLOQ <LLOQ 0.130 0.311 0.883 8.28 12.7 
TNF-α 0.412 (0.240) 84.2 <LLOQ <LLOQ 0.126 0.256 0.595 2.90 13.5 
IL-5 0.234 (0.230) 73.0 <LLOQ <LLOQ <LLOQ 0.102 0.263 0.745 4.66 
IL-12 p70 0.338 (0.217) 72.2 <LLOQ <LLOQ <LLOQ 0.308 0.750 1.73 2.35 
a: mean (standard deviation) 
 
Plasma samples had a greater percentage of samples (87.9%) that were above the LLOQ when 
compared to the EBC (80.6%) and urine (87.2%) samples.  IL-4, IL-5, IL-8, IL-10, and TNF-α 
had the largest %>LLOQ in both plasma and EBC.  IL-12p70 also had a large %>LLOQ in 
plasma, but was low in EBC and urine.  IL-1β, IL-2, and IL-13 had the smallest %>LLOQ in the 
blood and EBC samples.  The urine samples were unique in that the %>LLOQ was largest for 
IL-1β and IL-2; these results are the exact opposite of those observed for blood and EBC.  
LLOQs for specific cytokines were usually similar across the three biological media (e.g. 
LLOQIL-2,blood≈ LLOQIL-2,EBC≈ LLOQIL-2,urine).  However, LLOQs for IL-5, IL-8, IFN-γ and TNF-
α varied considerably across the three media, by as much as an order of magnitude.  These 
variations did not appear to appreciably affect the percentage of measurements above these 
values.  For example, IL-8 in the blood, EBC and urine samples had mean LLOQs of 
0.056pg/mL, 0.369pg/mL, and 0.116pg/mL, respectively, but 100, 92.2, and 93.8 percent of 
samples above the LLOQ.      
The cytokine concentrations were observed across wide ranges (Tables 2.4, 2.5, and 2.6), 
spanning 2-4 orders of magnitude (Min-Max) depending on the cytokine and the biological 
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medium.  Investigating individual cytokines across the different biological media shows that they 
have different concentration ranges from media to media.  For example, IL-8 ranged from 0.980-
41.7pg/mL in blood, <LLOQ-222pg/mL in EBC, and  <LLOQ-2270pg/mL in urine, 
demonstrating a wide range across the three media for this specific cytokine.  In contrast, IL-
12p70 had concentration ranges across the three biological media that were very similar to one 
another; IL-12p70 ranged from <LLOQ-1.62pg/mL in blood, <LLOQ-2.08pg/mL in EBC, and 
<LLOQ-2.35pg/mL in urine.  There were also large ranges exhibited within each biological 
media.  For example, the maximum concentrations in blood ranged from 0.633pg/mL for IL-2 to 
41.7pg/mL for IL-8.  The maximum concentrations in the EBC samples ranged from 
0.368pg/mL for IL-5 to 222pg/mL for IL-8, and the maximum concentrations in urine ranged 
from 2.35pg/mL for IL-12p70 to 2270pg/mL for IL-8. 
Table 2.7 displays estimated variance components, fold-ranges, and ICCs based on 
measurements of study plasma, EBC, and urine samples.  Here, ߪො௪௒ಳଶ , ߪො௕௒ಳଶ , and ߪො௒ಳଶ  are the 
estimated within, between, and total variance for the respective cytokine in each biological 
medium.  w ෠ܴ0.95B is the estimated fold-range containing the central 95% of cytokine 
measurements for any given person in the sampled population.  The parameter b ෠ܴ0.95B represents 
the estimated fold-range containing the central 95% of mean cytokine levels across all 
individuals in the sampled population.  Finally, Y ෠ܴ0.95B represents the estimated overall fold-
range containing the central 95% of all measurements for all individuals in the sampled 
population.        
 
 
 
 
 
 
Table 2.7: Estimated Variance Components, Fold-ranges, and ICCs for the Study Samples 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*All parameters were estimated using natural logged cytokine concentrations 
  Blood* EBC* Urine* 
Cytokine 
ߪො௪௒ాଶ  
(w ෠ܴ0.95B) 
ߪො௕௒ాଶ   
(b ෠ܴ0.95B) 
ߪො௒୆ଶ  
(Y ෠ܴ0.95B) ρො୆ 
ߪො௪௒ాଶ  
(w ෠ܴ0.95B) 
ߪො௕௒ాଶ   
(b ෠ܴ0.95B) 
ߪො௒୆ଶ  
(Y ෠ܴ0.95B) ρො୆ 
ߪො௪௒ాଶ  
(w ෠ܴ0.95B) 
ߪො௕௒ాଶ   
(b ෠ܴ0.95B) 
ߪො௒୆ଶ  
(Y ෠ܴ0.95B) ρො୆ 
IL-1β 0.954 (46.0) 
1.21 
(74.7) 
2.16 
(320) 
0.559 0.360 
(10.5) 
1.71 
(170) 
2.07 
(283) 
0.826 0.479 
(15.1) 
0.373 
(11.0) 
0.853 
(37.4) 
0.438 
IL-2  0.329 (9.48) 
0.492 
(15.6) 
0.821 
(34.9) 
0.599 0.608 
(21.2) 
2.72 
(642) 
3.33 
(1280) 
0.817 0.280 
(7.95) 
0.134 
(4.21) 
0.414 
(12.5) 
0.324 
IL-4 0.263 (7.46) 
0.012 
(1.53) 
0.275 
(7.80) 
0.043 0.065 
(2.71) 
1.06 
(56.1) 
1.12 
(63.3) 
0.942 0.910 
(42.1) 
0.372 
(10.9) 
1.28 
(84.7) 
0.290 
IL-5 0.491 (15.6) 
0.543 
(18.0) 
1.03 
(53.8) 
0.525 0.124 
(3.97) 
0.824 
(35.1) 
0.947 
(45.4) 
0.870 0.262 
(7.43) 
0.388 
(11.5) 
0.650 
(23.6) 
0.597 
IL-8 0.169 (5.01) 
0.080 
(3.03) 
0.249 
(7.06) 
0.321 0.745 
(29.5) 
1.82 
(197) 
2.56 
(530) 
0.709 1.33 
(92.4) 
1.81 
(195) 
3.14 
(1040) 
0.576 
IL-10 0.101 (3.46) 
0.146 
(4.48) 
0.247 
(7.00) 
0.593 0.064 
(2.70) 
0.303 
(8.65) 
0.367 
(10.8) 
0.825 0.525 
(17.1) 
0.219 
(6.27) 
0.744 
(29.4) 
0.295 
IL-12 p70 0.095 (3.35) 
0.155 
(4.68) 
0.250 
(7.09) 
0.620 0.083 
(3.09) 
0.973 
(47.8) 
1.06 
(56.2) 
0.921 0.213 
(6.10) 
0.126 
(4.03) 
0.339 
(9.80) 
0.372 
IL-13 0.301 (8.60) 
1.08 
(58.2) 
1.38 
(99.4) 
0.781 0.100 
(3.45) 
2.17 
(320) 
2.27 
(365) 
0.956 0.303 
(8.65) 
0.158 
(4.74) 
0.461 
(14.3) 
0.342 
INF- γ 0.325 (9.36) 
1.09 
(60.2) 
1.42 
(107) 
0.771 0.109 
(3.65) 
1.72 
(170) 
1.83 
(200) 
0.940 0.393 
(11.7) 
0.326 
(9.36) 
0.719 
(27.7) 
0.453 
TNF-α 0.055 (2.50) 
0.104 
(3.54) 
0.159 
(4.77) 
0.655 0.253 
(7.18) 
1.65 
(155) 
1.91 
(224) 
0.867 0.158 
(4.75) 
0.134 
(4.19) 
0.292 
(8.32) 
0.458 
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Total fold-range estimates (Y ෠ܴ0.95B) were between 4.77 and 320 for blood, 8.32 and 1040 for 
urine, and 10.8 and 1280 for EBC.  These results suggest that total measurement variability was 
similar for urine and EBC, but somewhat smaller for blood.  For the majority of the cytokines in 
blood (8/10 cytokines) and EBC (10/10 cytokines), b ෠ܴ0.95B was larger than w ෠ܴ0.95B.  However, the 
opposite trend was observed for urinary cytokines, where, for 8 out of 10 analytes, fold-range 
estimates were larger within-person than between-person.   
Large differences were also observed between the estimated within- and between-person 
fold ranges for specific cytokines across the three biological media.  Considering results for IL-4, 
w ෠ܴ0.95B values were 7.46, 2.71, and 42.1, and b ෠ܴ0.95B values were 1.52, 56.1, and 10.9 for blood, 
EBC and urine, respectively.  IL-4 is also interesting in that it is one of two cytokines in blood 
that had more estimated within-person variance than between-person variance.  IL-2 is a more 
extreme example of large differences in FRs having Y ෠ܴ0.95B for blood, EBC and urine of 34.9, 
1280, and 12.5, respectively.   
Observations across biological media show that the estimated mean ICCs for the blood 
and EBC samples are 0.547 and 0.867, indicating that the majority of the variance in cytokine 
concentrations for these two biological media was observed between-people.  Alternatively, the 
mean ICC across the urinary cytokines was 0.415 (i.e. more within-person than between person 
variance).  The results do not show a consistent trend across cytokines (i.e. an increase/decrease 
in within- or between- person variance) and media.  This demonstrates that despite an overall 
across-media trend (more between-person variance for blood and EBC and within-person 
variance for urine), the actual source of variation is dependent not only on the medium but also 
on the specific cytokine.  These ICC results, and the accompanying variance results that 
comprise the ICC, are consistent with the fold range result. 
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The next step in this analysis was to investigate the relationship between the ten 
cytokines in matched blood and EBC samples (n=77).  These results show that all of the EBC 
cytokines, except IL-1β, are positively correlated with one another, and that the blood samples 
have a mix of positive and negative correlations (Figure 2.2).  The Blood/EBC correlations have 
positive and statistically significant correlations for most cytokines, except IL-1β, IL-4, IL-5, and 
IL-10.  Correlation coefficients ranged from -0.620 to 0.836 for the blood/blood comparisons, -
0.045 to 0.852 for the EBC/EBC comparisons, and -0.236 to 0.600 for the blood/EBC 
comparisons.  The intensity of the colors in Figure 2.2 (i.e. the movement toward solid red for 
positive correlations and solid blue for negative correlations) shows that there are stronger 
relationships within a single media when compared to the relationships between the two media. 
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Figure 2.2: Cytokine Correlations (Spearman “Rho”) between Blood Plasma and Exhaled 
Breath Condensate.   
* 
A white dot in a cell denotes a statistically significant (p<0.05) positive or negative correlation. 
 
 
2.4 Discussion 
 
In this study, the main goal was to assess the feasibility of using an existing analytical 
method to identify target biomarkers of interest, simultaneously, in three different biological 
media.  To our knowledge, this is the first time that blood, EBC, and urine samples from a 
healthy adult population have been analyzed using a Th1/Th2 cytokine suite.  This work 
demonstrates a number of characteristics of human cytokine measurement and variability that 
have been previously unknown, and also extends the trace-level measurements further to 
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encompass EBC and urine samples as a complement to blood/plasma data.  These new 
observations can be categorized as follows: 
2.4.1 Calibration 
During initial tests, the ostensible calibration range of the instrument needed to be 
adjusted to address the low concentrations that were found in nominally healthy subjects.  The 
instrumentation provides signal “count” numbers beyond the internal calibration default values, 
and so a set of equations were developed that could be used to interpolate such results back to a 
new LLOQ.  The 5-parameter logistic model was chosen for these concentrations calculations 
primarily based on the range and shape (log-normally distributed) of the data, and the ability the 
model to interpolate low-end signals, averaging 8.85% more samples across the three biological 
media.  Experience with the 5pl model showed that the LLOQ could be decreased even lower 
using calibration strategies (based on trial and error) wherein individual cytokines were tested at 
vanishingly low concentrations to assess the empirical quantitation limits. 
 
2.4.2 Sensitivity and Method Precision 
 
Our study results showed that the methodology based on the MSD immunochemistry 
instrumentation is well suited for measuring cytokines in three different biological media 
(plasma, EBC, and urine) at the extremely low concentrations expected in samples from the 
general population.  This is particularly important for levels in exhaled breath condensate and 
urine, as these biological fluids represent “non-invasive” sampling pathways (in contrast to blood 
collection) and so are attractive for public health surveillance.  The MSD instrument can achieve 
robust detection levels better than the nominal design criteria and the results show that the 
sensitivity requirements for the instrumentation are in the 0.01 pg/ml range (see Tables 2.4, 2.5, 
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and 2.6).  However, at some point, the signal can no longer be considered distinct from noise and 
the experimental results usually had some measurements that were labeled “below LLOQ”. 
As shown in Table 2.2, the majority of the within- and between-plate variance for the 
spiked calibration samples lies within a plate, as such, any between-plate variance can be 
attributed to random error.  This result was expected; the internal calibration standards on each 
plate adjusted the samples accordingly so that samples analyzed on different 96-well plates could 
be compared to one another.  The next step in the analysis, the introduction of the three 
biological media through the duplicate sample analysis, showed that in most cases there was an 
increase in variation.  Once again, this was an expected outcome because the addition of a 
complex biological matrix often degrades measurement specificity and precision.  The variation 
and fold-ranges remained similar to that of the lowest spiked concentration, thus it was 
concluded that blood, EBC, and urine could be analyzed effectively and with the same amount of 
measurement variation as the “best case” scenario.  In summary, these results showed that the 
method had the necessary sensitivity and precision to analyze “real world” samples from three 
different biological media.  
 
2.4.3 Study Sample Cytokine Measurement Distributions and Correlations 
 
As seen in Table 2.4, 2.5, and 2.6, the MSD instrument is capable of developing cross-
media cytokine data from nominally healthy human subjects.  This is an important result because 
most previous work studied unhealthy patients where the inflammatory markers were already 
expected to be at high levels.  Having access to robust “control” level statistics is necessary for 
the discovery of in vivo perturbations from the status quo.  Furthermore, this allows us to make 
robust statistical comparisons from case-control studies without having to compare to “0”, but to 
defensible low numbers for the control groups. 
 40
Given the available blood, EBC, and urine data, the final step of this analysis was to 
investigate intra-class and Spearman correlations between the different cytokines and across the 
three biological media.  The expectation was that the majority of the ICCs would show more 
between-person variation than within-person variation, given that people live in their own 
“micro-environments” where they have their own exposures from food, water, air, behaviors, 
etc., and genetics that are different from one another.  However, this was not the case for all 
cytokines and all three media.  The plasma results showed that the variance in the expression of 
IL-4 and IL-8 are seemingly independent of the individual (i.e. everyone in the “group” looks 
similar to one another) and all urinary cytokines except for IL-5 and IL-8 displayed this same 
trend.  There is an opposite trend for the remaining cytokines in blood and all ten cytokines in 
EBC, where the results indicate that any variance is dependent on the individual.  From these 
results it is notable that the choice of biological medium plays a large role in the ICC, as 
evidenced by the blood/EBC difference for IL-4 (0.043 and 0.942 for blood and breath, 
respectively) and the EBC/urine difference for IL-4 ( 0.942 and 0.290 for EBC and urine, 
respectively).  It is also evident that individual differences, whether genetic, lifestyle, etc., likely 
play an important role in these intraclass correlations.   
Within a single medium, the pro-inflammatory cytokines (IL-1β, IL-2, IL-8, IL-12p70, 
IFN- γ, and TNF- α) should have positive Spearman correlations with themselves and negative 
Spearman correlations with the anti-inflammatory cytokines (IL-4, IL-5, IL-10, and IL-13).  
However, this was not the case for IL-1β for the within-media EBC comparison in Figure 2.1.  
This cytokine has a negative correlation with all other cytokines, including the cytokines in their 
respective “inflammatory” classification. All other EBC cytokines co-vary sufficiently to 
essentially provide the same information about a particular subject.  However, the blood and 
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EBC cytokine correlations are mixed and seemingly do not show a pro/anti inflammatory or a 
Th1 (IL-1β, IL-2, IL-12, IFN- γ, and TNF- α)/Th2 (IL-4, IL-5, IL-10, IL-13) “pattern”.  These 
results could be indicative of a differential response/expression of cytokines by the individual 
subjects in our study, but investigating these specific relationships is beyond the scope of this 
paper. 
The second overall outcome of the study showed that cytokine measurements in different 
media do not tell the same inflammatory story.  Although this result was anticipated based on the 
biological media and expected location of inflammation, for example urinary cytokines are likely 
more closely linked to kidney/bladder function and EBC cytokines are more likely linked to 
respiratory inflammation, there was one noteworthy trend.  Four of the five pro-inflammatory 
cytokines in blood had statistically significant correlations for the majority of the blood/EBC 
comparisons (Figure 2.2), showing that as they are expressed in one medium, they are 
distributed, or also expressed, in the other medium.  It is expected that with further investigation 
these relationships can be solidified and the use of blood as a “gold standard” could shift in the 
direction of less-invasive breath collection techniques, even when trying to look at inflammation 
that is not respiratory/pulmonary related.  
 To note, these results were interpreted solely based on biological medium classification 
and not on the Th1/Th2 profile or an anti/pro inflammatory profile.  This analysis has inherent 
limitations for assigning concrete relationships based on the progenitor cell and inflammatory 
classifications.  The only goal here is to illustrate the within or between person variation for 
these cytokines and the three biological media; a more comprehensive analysis of the ten 
cytokines in this panel could potentially produce a pattern related to the Th1/Th2 profile or 
anti/pro inflammatory profile, but this is beyond the scope of this work.    
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2.5 Conclusions 
 
These results demonstrate that the method is sufficiently robust to address the complexity 
of matrix inferences that are often seen when searching for the same biomarker in three different 
biological media and that the cytokines measured in this study can be identified and quantified at 
ultra-trace levels.  Furthermore, despite the fact that cytokines are often highly correlated within 
matrices, the between matrix results can be quite different.  The presented data can be used to 
guide future studies, and perhaps streamline new work, by focusing only on a few cytokines 
wherein the combination of sensitivity and correlation give optimal results at lower cost, or that a 
less invasive sampling medium (EBC or urine) could be substituted for blood collection.  This is 
especially valuable for targeted studies wherein a pre-existing hypothesis is to be tested and there 
may be no need to measure a 10-plex suite when two or three cytokines with the best range, 
sensitivity, and precision would produce equivalent results. 
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CHAPTER 3 
 
Diesel Exhaust and Ozone Inhalation Exposures affect Inflammatory Cytokine Levels and 
White Blood Cell Counts 
 
(Stiegel MA, Pleil JD, Sobus JR, and Madden MC. Diesel exhaust and ozone inhalation 
exposures affect inflammatory cytokine levels and white blood cell counts. 2014, in preparation) 
 
3.1 Introduction 
 
It is well known that the external environment plays an important role in the variation in 
response between an exposure and a health outcome, and it has been proposed that this response 
is more closely related to the external environment than any other contributing factor (Pleil, 
2012; Rappaport and Smith, 2010).  The environment contains of a myriad of chemicals that can 
partition into human systems biology via dermal, inhalation and ingestion routes, and so may 
influence the health-state by exposome x genome interactions (Pleil et al., 2011; Pleil and 
Sheldon, 2011; Wild, 2005).  Barring very detailed “discovery” style analyses, however, 
standard environmental monitoring is generally relegated to a set of “targeted” compounds (Pleil 
and Stiegel, 2013).  As such, exposure research is often deliberately limited to specific 
compounds of interest (usually, those that may be subject to regulation) and so the focus is 
narrowed toward specific pollutant-induced biological responses within a person (Brunekreef 
and Holgate, 2002; Campo and Castanas, 2008; Clean Air Act, 1963).  However, human-based 
exposure assessment cannot proceed with the same large ranges of dose-response methods that 
are utilized or calculated in other study designs (i.e. in vivo non-human animals, in vitro, or in 
silico) (Dix et al., 2007; Knudsen et al., 2013).  In contrast to standard invasive animal and 
cellular experiments, humans can only be purposely exposed to relatively harmless levels under
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strict guidelines, which often include exposures that may be similar, or lower than, what might 
be experienced by the general public in certain industrial or urban areas.  As such, the biological 
or metabolic responses may be correspondingly subtle, especially when the most sensitive 
populations cannot be ethically studied.  However, the advantage of using limited deliberate 
exposures, albeit at low dose-response regimes, is that the exposure is exactly characterized and 
stable.  Therefore, even subtle responses in biomarkers and biologically relevant markers can 
take statistical meaning.  
  One approach is to select specific human volunteers for highly-controlled chamber 
studies, which allow a scripted scenario wherein there is little environmentally-related temporal 
variation and each subject experiences exactly the same exposure levels, thus limiting the 
variation in the observed response; some of the important chamber studies include those used to 
develop pharmacokinetic models for trichloroethylene (TCE), methyl tertiary butyl ether 
(MTBE), chloroform, diesel exhaust (DE), wood smoke, and benzene (Buckley, 1997; Kim et 
al., 2007; Lindstrom and Pleil, 1996; Lindstrom et al., 1997; Pleil et al., 1996; Wallace et al., 
1997; Weisel et al., 1996).  Biomarker statistics and distributions can be achieved based on 
internal individual response while excluding extraneous and unknown external influences (Pleil, 
2009; Sobus et al., 2010).  These types of studies are usually employed to gain an understanding 
of the time course and underlying biological variance associated with the exposure.  The 
downside is that these studies are expensive, require complex infrastructure, and are generally 
limited few subjects that limit the extension of results sub-populations.   
One variant of scripted chamber studies is the “non-chamber” observational intervention 
study wherein pre- and post-measurements are made of a particular event, such as swimming in a 
chlorinated pool, showering in contaminated water, refueling a car, performing aircraft 
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maintenance, or firefighting (Lindstrom et al., 1997; Lindstrom and Pleil 1996a; Lindstrom and 
Pleil, 1996b; Pleil et al., 2000; Pleil et al., 2014).  Although these studies are less resource 
intensive than their chamber counterparts and yet still have a longitudinal component that allows 
estimates of absorption and elimination kinetics, they are not exactly controlled and thus incur 
greater data variance. 
Cross-sectional observational epidemiological studies have shown that DE and O3 can 
create or exacerbate cardiopulmonary health effects in humans, but there is still a need to 
understand the biological mechanisms that are responsible for any exposure-related biological 
response (Brook et al., 2010; Chuang et al., 2007; Faustini et al., 2013; Gold et al., 2000; Jerrett 
et al., 2009; Pope et al., 2006; Sydbom et al., 2001).  In vivo non-human animal models are more 
developed than their human-based counterparts and have shown links between DE-only or O3-
only exposures, the inflammation caused by these exposures, and other cardiopulmonary 
responses.  Stevens et al. 2008, investigated DE exposures on BALB/c mice and found up-
regulation of “inflammatory cytokines (IL-1β, CXCL2 [mouse equivalent of IL-8]” and 
“numerous interleukins and TNF subtypes” in bronchoaveolar lavage fluid (BALF) following the 
DE exposure.  A follow-up study by the same group found that the DE exposure caused an 
increase in Th2-associated cytokines (IL-5 and IL-10) but not Th1 cytokines (IL-12 and IFN-γ) 
(Stevens et al., 2009).  This shift, or polarization, toward Th2 (IL-4, IL-5, IL-10, and IL-13) 
cytokines is indicative of phagocyte-independent allergic immune responses and can also inhibit 
Th1 cytokine (IL-2, IL-8, IL-12p70, IFN-γ, and TNF-α) synthesis and response (cell-mediated 
immunity and phagocyte-dependent inflammation) (Cousins, 2002; Chung and Barnes, 1999; 
Romagnani, 2000).   
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Non-human animal exposure studies have also shown a relationship between changes in 
the expression of white blood cells (WBCs) following DE and O3 exposures (Kodavanti et al., 
2011; Laskin et al., 2010).  WBCs use cytokines to communicate with cells of the immune 
system, and increases in specific WBCs and cytokines can be linked to inflammatory responses.  
Kodavanti et al. 2011, studied cardiopulmonary biomarkers of injury in male Wistar Kyoto rats 
following exposure to DE, O3, or combination of DE+O3.  Their results showed decreasing 
concentrations of peripheral lymphocytes following the DE and O3 exposures and a significant 
increase in neutrophils (in BALF) following the DE exposure.  The results also showed up-
regulation of mRNA expression for some of the injury biomarkers for both the DE and O3 
exposures.  However, the DE+O3 co-exposure did not display any changes in WBC counts or 
cardiopulmonary biomarkers of injury. 
There are several human-based controlled chamber studies that address the relationship 
between DE-only and O3-only exposures and the resulting innate immune system response.  
Holgate et al. 2003, through a series of DE chamber studies, discovered: increased neutrophils 
and IL-8 mRNA expression (at 300 pg/m3 x 1-hour exposure), and increased lymphocytes (in 
BALF), IL-8 (in BALF), and neutrophils (in bronchial wash fluid) in a 2-hour exposure at 100 
μg/m3.  However, they did not see DE exposure-related increases in any of the other measured 
inflammatory cytokines.  Törnqvist et al. 2007, investigated DE exposure (300 μg/m3 x 1-hour 
exposure) on 15 healthy male volunteers and found statistically significant increases in IL-6 and 
TNF-α 24-hours after the exposure, but no change in circulating neutrophils.  Xu et al. 2013, 
studied 18 healthy volunteers exposed to 300g/m3 of DE for 3 hours and discovered a 
significant increase in peripheral blood monocyte and leukocyte counts, but no change in any of 
the other WBCs or any inflammatory cytokines.  Devlin et al. 2012, investigated 2-hour O3 
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exposures at 0.3ppm with 23 healthy volunteers and the results showed statistically significant 
increases in cytokines IL-1β, IL-8, and TNF-α as well as a statistically significant increase in 
BALF-measured neutrophils.  Alexis et al. 2010, studied 15 healthy volunteers that were exposed 
to 0.08 ppm of O3 for 6.6 hours and found significant increases in sputum-acquired neutrophils, 
dendritic cells and cytokines (IL-6, IL-8, IL-12p70, and TNF-α) 18 hours after the end of the 
exposure.  Finally, Kim et al. 2011, investigated O3 exposure (0.06ppm for 6.6 hours) responses 
for 59 healthy young adults and saw a statistically significant increase in sputum-acquired 
polymorphonuclear neutrophils (PMN) following the O3 exposures.     
Given that there is scientific evidence for exposure-related inflammatory responses from 
separate DE and O3 exposures in both humans and rodents, it is prudent to investigate their co-
exposures to assess potential synergistic effects (Bosson et al., 2008).  To our knowledge, there 
are currently no studies that have systematically investigated a mixture of DE and O3.  
Understanding any links between exposures and a biological response is pertinent to 
understanding the underlying biological exposure-response mechanisms and thus the risk 
associated with co-exposure to DE and O3, especially for the identification of susceptible sub-
populations.  The overall goal for this study is to explore cells and proteins of the innate immune 
system (i.e. inflammatory cytokines and WBCs) and their relationship to DE, O3, and DE+O3 co-
exposures.  Establishing these links is beneficial in that it will provide evidence in humans 
regarding the underlying systems biology in measureable changes in specific blood cell types 
and provide unambiguous links between exposures and cardiopulmonary effects as mediated by 
the inflammatory response. 
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3.2 Methods 
 
3.2.1 Study Population 
 
 Briefly, all subjects were recruited into the study under the following criteria: 18-55 years 
old, healthy (meaning that they did not have a medical condition of any kind), had to be able to 
exercise for 4, 15 minute, increments over a 2 hour time frame on a recumbent bike at a target 
minute ventilation rate of 25 L/min*body surface area, were non-smoking, and had to be willing 
to discontinue use of non-steroidal anti-inflammatory drugs (NSAIDs), vitamin C, and vitamin 
E.  Table 3.1 displays the demographics for the study subjects.  Further description of the 
protocol can be seen in Madden et al. 2014 (IRB Study #: 09-1344).    
Table 3.1: Demographics of Study Participants for Selected Samples 
  Race N BMI1 Age2 GSTM13 
Male (n=11) 
Hispanic  2 
26.5 (24.7-28.3) 27.3 (24.4-30.5) 6+/4-/1nd 
Non-Hispanic 
Black  2 
Non-Hispanic 
White  7 
Female (n=4) 
Hispanic  0 
30.7 (21.7-39.7) 26.2 (22.9-29.9) 3+/1- 
Non-Hispanic 
Black  2 
Non-Hispanic 
White  2 
1 mean (µ) and 95% confidence interval of the µ 
2 geometric mean (GM) and 95% confidence interval of the GM 
3 GSTM1 genotype status (+ = positive, - = null, nd=no determination) 
 
3.2.2 Exposure Scenario: Highly-Controlled Environmental Exposure Chamber 
 
The experimental design for this study was a random-crossover double-blind study with 
four exposure arms, where each arm was separated by at least 13 days.  Each participant was 
exposed in an environmentally controlled exposure chamber at the US EPA Human Studies 
Facility (Chapel Hill, NC) to clean air, DE (300 μg/m3), O3 (0.3 ppm), or a combination of DE 
and O3 for 2 hours.  The environmental exposure order was random, with the participant 
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commencing the study in any of the four exposure arms and progressing though the remaining 
three arms over the next 2-3 months.  The first day of exposure (i.e. clean, DE, O3, DE+O3) was 
always followed by an O3 exposure day with a third day for medical follow-up.  Figure 1, below, 
illustrates the four exposure arms and the exposure schedule.  This paper investigates the 
relationship between the “Pre” and “Post” samples on Day 1 as well as the “Pre” sample on Day 
2, for each exposure; as such, the potential short term “priming” effects of recent exposure are 
avoided.  The deliberate limitation of this analysis to the first 24 hours of the study was to focus 
the scope on the individual exposure(s) before proceeding to a secondary analysis where 
interaction effects following the contribution of a secondary (i.e. O3) exposure could be 
investigated. 
Figure 3.1: Exposure schedule for volunteers. Each exposure arm is composed of three days* 
  
* Day 1 is one of the four exposures (clean air, DE, O3, and DE+O3), Day 2 is always O3, and Day 3 has no 
exposure. 
 
3.2.3 Sample Collection and Analysis 
 
180 blood samples were collected from fifteen healthy human volunteers.  The collection 
and analysis is described in more detail in Stiegel et al. 2014, but briefly, it proceeded as follows.  
Whole blood was collected in EDTA-containing 10mL Vacutainer® (Product Number: 368589, 
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Becton, Dickinson and Company, Franklin Lakes, New Jersey) collection tubes, centrifuged, 
aliquotted, and then frozen at ≤-80°C until analysis.  The plasma fraction from the whole blood 
samples were analyzed using Human Th1/Th2 10-plex Ultra-Sensitive Kits and a Meso Scale 
Discovery (MSD) SECTOR Imager 2400 (Meso Scale Discovery, Gaithersburg, MD) for the 
following cytokines: interleukins 1β, 2, 4, 5, 8, 10, 12p70 and 13, IFN-γ, and TNF-α. 
GSTM1 status was determined from isolated peripheral white blood cell DNA using 
QIAamp DNA real-time polymerase chain reaction Mini Kits (Qiagen Inc., Valencia, CA) and 
the white blood cell counts were ascertained by LabCorp (Laboratory Corporation of America 
Holdings, Burlington, NC) (Gilliland et al., 2002; Kim et al., 2011). 
 
3.2.4 Statistical Analysis 
 
The 10 cytokines and 3 white blood cells for each exposure and treatment day were tested 
for normality using Shapiro-Wilks tests (Proc UNIVARIATE, SAS statistical software package 
version 9.3, SAS institute, Cary, NC).  All white blood cells were normally distributed, and 
cytokine data that were right-skewed were natural log-transformed to satisfy assumptions of 
normality (see Table 2).  The relationships between the pre-exposure (Day 1) and post-exposure 
(Day 1) cytokine concentrations, and the pre-exposure (Day 1) and follow-up (Day 2) cytokine 
concentrations for each treatment were investigated using paired student t-tests.  Wilcoxin 
matched-pairs signed rank tests were used for the data that were not normally distributed. P-
values <0.05 and 0.05<p<0.10 were considered statistically significant and “moderately” 
statistically significant, respectively.  This analysis had the following a priori hypotheses: 
1.There will be no change in the expression of the cytokines for the control (i.e. clean) 
exposure however there will be an increase in the expression of the pro-inflammatory 
cytokines for the other three (DE, O3, and DE+O3) exposures. 
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2.The expression of the pro-inflammatory cytokines in the DE+O3 co-exposure will 
exhibit a synergistic relationship when compared to the single DE or O3 exposures.  
3.The anti-inflammatory cytokines will show no change in expression for any of the four 
treatments. 
The relationships between the pre-exposure (Day 1) and post-exposure (Day 1) white blood cell 
percentages, and the pre-exposure (Day 1) and follow-up (Day 2) white blood cell percentages in 
each treatment were investigated using one-way analysis of variance (ANOVA) with 
Greenhouse-Geisser corrections and Tukey’s post-hoc tests for multiple comparisons.  The 
multiple comparisons used an α=0.05 and multiplicity adjusted p-values.  The multiplicity-
adjusted p-values are reported for tests that had statistically significant differences.  Finally, 
given the results from the cytokine and WBC comparisons, Spearman correlation coefficients 
were calculated only for the DE+O3 co-exposure.   
 
3.3 Results 
 
3.3.1 Descriptive Statistics for the Four Exposures 
 
Figure 3.2, below, displays the cytokine concentrations for all days and exposures. There 
are two distinct groups of subjects as well as individual differences.  Seven (subjects 3-9) of the 
15 subjects have higher concentrations of IL-1β and IL-10 but lower concentrations of IL-2, IL-
12p70, IL-13 and IFN- γ when compared to the rest of the group (subjects 1, 2, 10-15).  The 
results for subject 5 indicate a change from the former group (high levels of IL-1β and IL-10) to 
the latter group for the DE, O3 and DE+O3 exposures.  IL-8, IL-10, and TNF-α have higher 
sustained concentrations across the two days when compared the other seven cytokines.  IL-8 
and TNF-α do show decreasing Pre-to-Post concentrations for the DE and DE+O3 exposures but 
not for the O3-only exposure where there is a Pre-to-Post increase in concentration.  Individual 
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increases for the O3-only exposure are also evident.  Subjects 2, 3, 10, and 11 have increasing IL-
8 and TNF-α concentrations following the O3 exposure while subject 15 has decreasing 
concentrations following exposure.  
Figure 3.2: Heatmap of the Plasma Cytokine Levels for All Exposure Treatments over a 24-hour 
Period* 
 
*The concentrations in Figure 3.2 increase as the color changes from blue to red. 
 
Descriptive statistics for each exposure and day are shown in Table 3.2.  The “pre” 
exposure concentrations for each exposure-arm on Day 1(as seen in Table 3.1) should be similar 
to one another, this holds true for all cytokines except for IL-1β on the “Pre”, “Clean” exposure.  
Looking at Figure 3.2, this result could be a bi-product of subject 3; the concentration of IL-1β 
for this participant is ~10pg/mL while the majority of the other subjects have concentrations 
≤1.0pg/mL.  Subject 3 is also part of the group (Subjects 3-9) that has increased levels of IL-1β 
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and IL-10 through all exposures. Looking across all exposures, IL-8 and TNF- α had the highest 
mean concentrations while IL-2 had the lowest mean concentration.  The majority of the 
cytokine concentrations in each of the DE, O3, and DE+O3 treatments decreased following the 
respective exposure.  The 10 cytokines had pre-exposure averages for the clean, DE, O3, and 
DE+O3 exposures of 1.28pg/mL, 0.903pg/mL, 1.17pg/mL, and 1.12pg/mL, respectively, while 
the “Post” averages for the clean, DE, O3, and DE+O3 exposures were 0.912pg/mL, 0.628pg/mL, 
1.13pg/mL, and 0.919pg/mL.  In each case, there was a decreasing overall mean trend, though 
change in the standard error for each cytokine, treatment, and day did not follow a similar 
pattern.  
Table 3.2: Descriptive Statistics by Exposure, for Plasma* 
 
 
 
 
 
 
 
 
 
 
 
*mean (+/- standard error), pg/mL, "^" denotes a non-parametric distribution 
 
Clean Diesel  O3 DE+O3 
Cytokine Pre Post Follow-up Pre Post 
Follow-
up Pre Post 
Follow-
up Pre Post Follow-up 
IL-1β 3.29 (2.65)^ 
0.872 
(0.280)^ 
0.598 
(0.188)^ 
0.932 
(0.498)^ 
0.741 
(0.235)^ 
0.746 
(0.323) 
1.16 
(0.337)^ 
1.04 
(0.268)^ 
1.19 
(0.321) 
2.20 
(0.149)^ 
0.622 
(0.472)^ 
0.976 
(0.485)^ 
IL-2 0.100 (0.0181) 
0.115 
(0.0219) 
0.105 
(0.0173) 
0.124 
(0.0212) 
0.103 
(0.0185) 
0.105 
(0.0194) 
0.205 
(0.0529) 
0.169 
(0.0543) 
0.143 
(0.0368) 
0.115 
(0.0740) 
0.132 
(0.0586) 
0.109 
(0.0183) 
IL-4 0.281 (0.0240) 
0.241 
(0.0153) 
0.283 
(0.0221) 
0.325 
(0.0214) 
0.313 
(0.0308) 
0.293 
(0.0228) 
0.749 
(0.236)^ 
0.714 
(0.210)^ 
0.698 
(0.222)^ 
0.402 
(0.259)^ 
0.374 
(0.246)^ 
0.413 
(0.164)^ 
IL-5 1.62 (1.34)^ 
0.940 
(0.741)^ 
0.400 
(0.142) 
0.306 
(0.114) 
0.210 
(0.0520) 
0.254 
(0.0535) 
0.307 
(0.0635) 
0.274 
(0.0658) 
0.329 
(0.0612) 
0.264 
(1.49) 
0.208 
(0.173) 
0.347 
(0.0797) 
IL-8 2.16 (0.200) 
1.89 
(0.145) 
2.03 
(0.166) 
2.09 
(0.185) 
2.02 
(0.183) 
1.90 
(0.192)^ 
2.68 
(0.450) 
2.95 
(0.701) 
2.33 
(0.371) 
2.27 
(0.0231) 
2.21 
(0.0283) 
2.15 
(0.195) 
IL-10 1.25 (0.152) 
1.14 
(0.124) 
1.18 
(0.124)^ 
1.12 
(0.126) 
1.07 
(0.127) 
1.08 
(0.130) 
1.56 
(0.226) 
1.43 
(0.175) 
1.35 
(0.183) 
1.19 
(0.116) 
1.68 
(0.0660) 
1.17 
(0.231) 
IL-12 p70 0.387 (0.0455) 
0.414 
(0.0487) 
0.397 
(0.0442) 
0.411 
(0.0492) 
0.396 
(0.0529) 
0.434 
(0.0571) 
0.583 
(0.116) 
0.577 
(0.140) 
0.545 
(0.111) 
0.498 
(0.0479) 
0.420 
(0.0290) 
0.481 
(0.0916) 
IL-13 1.27 (0.279)^ 
1.19 
(0.250)^ 
1.29 
(0.246)^ 
1.20 
(0.220)^ 
1.08 
(0.225)^ 
1.20 
(0.231)^ 
1.52 
(0.353)^ 
1.56 
(0.337)^ 
1.49 
(0.308)^ 
1.45 
(0.240)^ 
1.36 
(0.272)^ 
1.50 
(0.303)^ 
INF-γ 0.480 (0.164) 
0.452 
(0.173) 
0.649 
(0.215) 
0.485 
(0.122) 
0.375 
(0.0987) 
0.486 
(0.159) 
0.301 
(0.0619) 
0.262 
(0.0581) 
0.277 
(0.0553) 
0.446 
(0.0900) 
0.322 
(0.0673 
0.296 
(0.0507) 
TNF-α 1.94 (0.174) 
1.87 
(0.146) 
2.05 
(0.197) 
2.04 
(0.190)^ 
1.79 
(0.177)^ 
1.98 
(0.214) 
2.59 
(0.513)^ 
2.35 
(0.426)^ 
2.36 
(0.344) 
2.35 
(0.336)^ 
1.86 
(0.192)^ 
2.13 
(0.289) 
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3.3.2 Exposure Responses – Pre vs. Post vs. Follow-up 
Matched, post-exposure to pre-exposure ratios and follow-up to pre-exposure ratios were 
created for each exposure and cytokine and displayed in Figures 3.3 and 3.4, below.  A ratio 
above “1” indicated that the “post” exposure concentration was higher than the “pre” exposure 
concentration and a ratio below “1” indicated the opposite.  Only statistically significant results 
are reported below; three (IL-1β, IL-10, and IL-13) of the ten cytokines had no statistically 
significant Pre-to-Post or Pre-to-FU differences.  
Figure 3.3: Post/Pre Exposure Cytokine Concentration Ratios for the Four Treatments 
   
 
A blue “dot” in Figure 3.3, above, is an individual Post/Pre exposure cytokine concentration ratio for that respective 
treatment.  A solid line in each of the cytokine scatterplots displays the median of post/pre exposure concentration 
ratio.  The dotted line that is anchored at “1” on each y-axis indicates the ratio where the Pre-exposure concentration 
is equal to the Post-exposure concentration.  A statistically significant result above/below “1” indicates that there has 
been an increase/decrease in the concentration for that respective cytokine at end of the 2-hour exposure period. 
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Figure 3.4: Follow-up/Pre Exposure Cytokine Concentration Ratios for the Four Treatments 
 
A blue “dot” in Figure 3.4, above, is an individual Follow-up/Pre exposure cytokine concentration ratio for that 
respective treatment.  A solid line in each of the cytokine scatterplots displays the median of follow-up/pre exposure 
concentration ratio.  The dotted line that is anchored at “1” on each y-axis indicates the ratio where the Pre-exposure 
concentration is equal to the Follow-up concentration.  A statistically significant result above “1” indicates that there 
has been an increase in the concentration for that respective cytokine 22-hours after the end of the 2-hour exposure 
period.  A statistically significant result below “1” indicates that there has been a decrease in the concentration for 
that respective cytokine 22-hours after the end of the 2-hour exposure period.     
 
Given that there was no “exposure” on Day 1 of the clean treatment, minimal Pre-to-Post change 
was expected following the 2-hour treatment period, but there were unanticipated results. The 
two anti-inflammatory cytokines, IL-4 and IL-5, had moderate and statistically significant 
decreases following the treatment, respectively, and IFN-γ, a pro-inflammatory cytokine, also 
had a statistically significant decrease.  The other pro-inflammatory cytokines (IL-2, IL-8, IL-
12p70, and TNF-α) had no statistically significant results.  IL-4, IL-5, and IFN-γ all have t-cells 
as their progenitor cell but IL-2 and TNF-α, the other two cells that can be produced by t-cells, 
 57
had no statistically significant results.  The lack of statistically significant results for IL-5 and 
IFN-γ in Figure 3b indicates that the cytokine levels return to their “Pre” exposure levels 22-
hours after the clean treatment.  However, IL-4 switches from a moderate statistically significant 
Pre-to-Post decrease to a statistically significant 22-hour post treatment increase.       
The median concentrations for the DE exposure all display a Pre-to-Post decrease.  
Similar to the clean treatment, IL-5 and IFN-γ have statistically significant decreases in cytokine 
concentration from the “Pre” values to the “Post” values however TNF-α also has a statistically 
significant decrease.  Unlike the clean treatment, there is no noticeable difference between either 
the pro- or anti-inflammatory classifications or which cell produces the cytokines of interest.  
There are no statistically significant results for the follow-up comparison (see Figure 3.4).   
The post-exposure results for the O3 exposure show that 5/7 cytokines have Post/Pre 
ratios that are below “1”, with IL-2 having a significant decrease and IL-5 and TNF-α having 
moderately significant decreases (see Figure 3.3).  These results are very similar to the DE 
results from Day 1; the Post/Pre ratios for the majority of the cytokines decrease however there 
are few statistically significant results.  All of the pro-inflammatory cytokines on Day 1 had 
decreasing median Post/Pre ratios and the two anti-inflammatory cytokines either had no change 
(IL-4) or exhibited decreasing (IL-5) median Post/Pre ratios.  The Follow-up/Pre ratios are 
unremarkable and all cytokines, except IL-2, have 22-hour post exposure concentrations that are 
similar to the Pre exposure concentrations.  Like the Pre-to-Post Day 1 decrease, IL-2 still 
displays a statistically significant decrease in expression following the exposure; the “post” mean 
for IL-2 (0.169pg/mL) is not statistically different (p=0.99) than the follow-up mean 
(0.143pg/mL).  The O3 samples also display a greater overall range of individual responses, as 
evidenced by the increase in scatter across the 7 cytokines.  
 58
  Day 1 of the DE+O3 co-exposure had 5/7 cytokines with decreasing median “Pre” to 
“Post” concentrations following exposure, with four (IL-5, IL-12p70, IFN-γ, and TNF-α) having 
statistically significant decreases (see Figure 3.3).  Three (IL-12p70, IFN-γ, and TNF-α) of these 
four cytokines are pro-inflammatory cytokines.  The other two pro-inflammatory cytokines, IL-2 
and IL-8, have increasing “Pre” to “Post” concentrations, though neither is statistically 
significant.  Figure 3.3 also shows that two (IL-12p70 and TNF-α) of the three cytokines that can 
be produced by macrophage have significantly decreasing pre to post medians.  As mentioned 
above, IL-5, an anti-inflammatory cytokine, also has a statistically significant “Pre” to “Post” 
decrease.  The most striking difference between the DE+O3 co-exposure and the other three 
treatments are the Follow-up/Pre ratios seen in Table 3.4.  The follow-up samples for IFN-γ and 
TNF-α are still significantly and moderately significantly less than the Pre exposure samples.  
However, IL-5 and IL-12p70, the other two cytokines that have significant pre-to-post decreases 
no longer display this trend.     
Figure 3.3 also illustrates the overall trend of Th1-mediated cytokine suppression for the 
DE, O3, DE+O3 exposures; changes in IL-5, a Th2 produced cytokine and seen across all 
exposures, are potentially related to the study design (i.e. the incremental exercise during the 
exposure) and are most likely not indicative of an environmental exposure-related effect.  The 
DE exposure shows IFN-γ and TNF-α having statistically significant decreases following 
exposure.  IL-2 and IFN-γ decrease following the O3 exposure, while IL-12p70, IFN-γ, and TNF-
α all decrease following the DE+O3 exposure.  Figure 3.4 shows that the Th1/Th2 “balance” in 
the DE exposure returns to baseline 22-hours after exposure, but IL-2 is still suppressed in the O3 
exposure and IFN-γ and TNF-α are still suppressed in the DE+O3 exposure.  In summary, there 
are more there are more exposure-related effects for the Th1 cytokines.  
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3.3.3 TNF-α 
 
The results for TNF-α stand out from the other 6 cytokines for the DE, O3, and DE+O3 
exposures.  Figure 3.5, below, shows that each median “Post” concentration for the three 
exposures is less than the “Pre” concentration for the respective day.  The “Post” concentrations 
for both the DE and O3 exposures are significantly and moderate significantly less than the “Pre” 
values, for the respective exposures.  These two exposures also show that the Follow-up median 
value is not statistically different from either the “Pre” or “Post” sample from Day 1. 
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Figure 3.5: TNF-α Cytokine Results for Three Exposure Scenarios 
 
The boxes in Figure 3.5, above, display the median, upper 75%, and lower 25% of the concentrations for TNF-α, 
while the bars display the upper 97.5% and the lower 2.5% of the concentrations.  This figure shows that the 
combination of the DE-only and O3-only exposures into a DE+O3 co-exposure creates a suppression of TNF-α that 
does not recover after a 22-hour period.   
 
The DE+O3 graph on the right side of Figure 3.5 shows that there are an increased 
number of statistically significant results when compared to the DE and O3 graphs on the left 
side of the figure.  Of particular note, there are no statistically significant results on Day 2 for the 
DE or O3 exposures, but the combination of these two exposures into the DE+O3 co-exposure 
produces a statistically significant result on Day 2.  The DE+O3 results show that TNF-α is 
suppressed by the Day 1 exposure and this suppression almost recovers in a 24-hour timeframe.  
Note that the median for Day 2 is higher than both the Pre and Post median for Day 1, but the 
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moderately significant result still shows an overall pre to follow-up decrease that is similar to the 
pre to post decrease.  
 
3.3.4 Cellular Response and Correlations with Cytokines 
 
Tables 3.3 and 3.4 display the white blood cell count results for the four exposures.  The 
three cell types have “Pre” mean concentrations (as seen in the “Abs. Lymph, Abs. Mono and 
Abs. PMN” rows) across the four exposures that are very similar to one another (Table 3.3).  The 
“Pre” averages (# cells 103/uL) and standard error (+/- # cells103/uL) for the lymphocytes, 
monocytes, and neutrophils for the four exposures are 1.93(0.066), 0.555(0.024), and 
3.02(0.106), respectively, showing that there is not a lot of variation in the counts before 
exposure. The percentage calculations display this same “Pre” trend as the absolute (Abs.) 
values.  The “Post” WBC values, both differential and absolute, vary based on the respective 
exposure.  The average absolute lymphocyte counts decreased for the clean, DE, and O3 
exposures but not for the DE+O3 exposure.  The DE and O3 exposures displayed “Pre” to “Post” 
increases for the monocytes, while the clean and DE+O3 exposures showed average decreases in 
the absolute monocyte concentrations.  All exposures had increasing average PMN 
concentrations with the DE and DE+O3 exposures having the largest increases.   
The “Pre” to “Post” differential counts were somewhat different from the absolute 
concentrations.  Changes in the absolute concentrations for some of the WBCs were reflected as 
a more significant change (and consequently indicated in the statistical tests in Table 3b) in the 
percentage of total WBC calculations.  For example, the DE exposure had Pre and Post absolute 
mean PMN differences of 0.84# cells*103/uL, while the DE+O3 exposure had very similar Pre 
and Post absolute mean PMN differences of 0.81# cells*103/uL.  However, this small difference 
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in absolute mean concentration translated into a Pre to Post percentage PMN increase of 8% for 
the DE exposure and 9.4% for the DE+O3 exposure. 
Comparing the pre-exposure to post-exposure results shows that the lymphocytes display 
statistically significant pre-to-post decreases for each of the exposures (see Table 3.4).  The 
monocytes also have significant pre-to-post decreases but only for the clean and DE+O3 
exposures.  All four exposures have significant pre to post increases for the neutrophil (PMN) 
differential counts, but only the DE and DE+O3 display statistically significant absolute count 
increases.  The DE-only exposure has the largest percentage decrease for the lymphocytes while 
the DE+O3 co-exposure has the largest decrease in percentage for the monocytes and the largest 
percentage increase in neutrophils.   
Table 3.3: Cell Count Descriptive Statistics by Exposure and Sample Timea 
   Exposure 
  Clean DE O3 DE+O3 
Day 1 
Pre 
% Lymph 34.4 (1.53) 36.1 (1.86) 34.7 (1.93) 36.2 (1.67) 
Abs. Lymph 2.01 (0.140) 1.97 (0.139) 1.87 (0.121) 1.90 (0.143) 
% Mono 10.1 (0.759) 9.13 (0.593) 10.1 (0.827) 10.3 (0.728) 
Abs. Mono 0.587 (0.046) 0.507 (0.037) 0.573 (0.067) 0.553 (0.038) 
% PMN 52.3 (1.69) 51.7 (1.81) 52.2 (1.97) 50.1 (1.68) 
Abs. PMN 3.18 (0.166) 3.01 (0.158) 3.11 (0.0323) 2.76 (0.146) 
Post 
% Lymph 28.7 (2.32) 29.0 (2.35) 30.5 (2.18) 30.0 (2.35) 
Abs. Lymph 1.87 (0.145) 1.80 (0.158) 1.85 (0.126) 1.90 (0.162) 
% Mono 8.73 (0.565) 8.73 (0.539) 9.40 (0.709) 8.47 (0.601) 
Abs. Mono 0.547 (0.038) 0.547 (0.040) 0.580 (0.066) 0.500 (0.037) 
% PMN 60.1 (2.56) 59.7 (2.46) 57.9 (2.23) 59.5 (2.57) 
Abs. PMN 3.85 (0.361) 3.85 (0.364) 3.52 (0.0307) 3.57 (0.288) 
Day 2 Follow-up 
% Lymph 33.3 (1.82) 34.7 (2.00) 35.6 (1.80) 33.5 (1.51) 
Abs. Lymph 1.83 (0.126) 1.93 (0.147) 1.87 (0.127) 1.80 (0.116) 
% Mono 10.2 (0.903) 9.40 (0.524) 10.5 (0.780) 10.2 (0.698) 
Abs. Mono 0.587 (0.056) 0.560 (0.036) 0.553 (0.047) 0.547 (0.042) 
% PMN 53.1 (1.79) 52.6 (1.90) 50.9 (1.74) 53.1 (1.53) 
Abs. PMN 3.42 (0.240) 3.14 (0.201) 2.69 (0.208) 2.85 (0.147) 
amean (+/- standard error), % = percent of total white blood cell count, Abs. = # cells*103/uL, Lymph = 
lymphocytes, mono = monocytes, PMN = polymorphonuclear neutrophil  
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Unlike the DE+O3 co-exposure, the clean, DE-only, and O3-only exposures have no significant 
Pre/Follow-up comparisons.  The percentage of lymphocytes in the total WBC count for the 
DE+O3 exposure is still significantly less than the “pre” exposure percentage 22 hours after the 
exposure, and the follow-up PMN percentages are still significantly more than the pre exposure 
percentages. 
Table 3.4: Pre, Post, and Follow-up Statistical Comparisons by Exposurea 
  Exposure 
  Clean DE O3 DE+O3 
  Pre vs. Post 
Pre vs. 
FU Pre vs. Post 
Pre vs. 
FU 
Pre vs. 
Post 
Pre vs. 
FU Pre vs. Post Pre vs. FU 
% Lymph - (0.0025) none - (<0.0001) none - (0.0306) none - (0.00140) - (0.0270) 
Abs. Lymph none none none none none none none none 
% Mono - (0.0359) none none none none none - (0.0140) none 
Abs. Mono none none none none none none none none 
% PMN + (0.0010) none + (0.0004) none + (0.0101) none + (0.0003) + (0.031) 
Abs. PMN none none + (0.0279) none none none + (0.0267) none 
a “+/-”= statistically significant increase/decrease, (p-value), % = percent of total white blood cell count, Abs. = # 
cells*103/uL, Lymph = lymphocytes, mono = monocytes, PMN = polymorphonuclear neutrophil, FU = follow-up 
sampling time on Day 2 
 
Given the statistically significant results for the DE+O3 co-exposure, correlations between the 
white blood cells and the cytokines were investigated.  Figure 3.6 shows some interesting 
Spearman correlations between the 7 cytokines and the 3 WBCs.  As expected, most of the 
cytokines and WBCs are highly correlated within themselves across the three time period 
comparisons (i.e. Pre/Post, Pre/Follow-up, and Post/Follow-up).  IL-8 is the only cytokine that 
does not follow this trend.  IL-8 does have negative Pre/Pre and Pre/Post correlations with TNF-
α, but no other correlations of importance.  
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Figure 3.6: Spearman Correlations for Pre, Post and 22-hour Post DE+O3 Co-Exposure 
Responses* 
 
*A white dot in a cell indicates a statistically significant (p<0.05) positive or negative correlation.  Lymph = 
lymphocytes, Mono = monocytes, PMN = polymorphonuclear neutrophil.   
 
IFN-γ has negative correlations with IL-4 for all comparisons, an interesting pro- vs. anti- 
inflammatory result.  IL-12p70 also exhibits some negative correlations but with IL-5, the other 
anti-inflammatory cytokine.  The WBCs maintain the same relationships with one another 
through all comparisons; the neutrophils are negatively correlated with the lymphocytes and the 
monocytes have no correlations with either the lymphocytes or the neutrophils.  The post-
exposure neutrophil percentages are positively correlated with the post-exposure IFN-γ 
concentrations while the post-exposure lymphocytes are negatively correlated with the post-
exposure IFN-γ concentrations. There are no post-exposure relationships for TNF-α with either 
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the lymphocytes or the neutrophils, but it is negatively correlated with the post-exposure 
monocytes.  The correlations between the WBCs and IFN-γ do not persist beyond the post/post 
comparison, but TNF-α does have a negative correlation with the monocyte percentages for the 
post/follow-up and follow-up/follow-up comparisons.  
Above, Table 3.3 shows that the mean lymphocytes percentages decrease from Pre to 
Post.  In the same respect, the mean IFN-γ concentrations also display a Pre to Post decrease, 
however, on an individual basis lymphocyte percentages increase as the IFN-γ concentrations 
decrease.  This is important because the neutrophils are positively correlated with IFN-γ.  The 
relationship is not as strongly correlated (ρ=0.416 vs. ρ=-0.500 for the IFN-γ/PMN vs. IFN-
γ/lymph comparisons, respectively) as the relationship with the lymphocytes, but this example is 
one of the few described occurrences. 
 
3.4 Discussion 
 
This study had two purposes: one, discover if any of the three exposures had an effect on 
the expression of the inflammatory cytokines and white blood cells, and two, investigate if any 
exposure-related changes were still present 22 hours later.  There was no expectation that the 
clean exposure would affect the expression of the pro-inflammatory (IL-1β, IL-2, IL-8, IL-
12p70, IFN-γ, and TNF-α) cytokines, but a small increase was expected from the DE-only and 
O3-only exposures, with a larger increase expected from the DE+O3 co-exposure.  There should 
be little, if any, statistically significant change in the expression of the anti-inflammatory (IL-4, 
IL-5, IL-10, and IL-13) cytokines for the Day 1 exposures. The expectation for the follow-up 
results on Day 2 were that any treatment effects from the filtered clean air, DE, or O3 on Day 1 
would be negligible 22-hours after the exposure.  The combination of DE and O3 should create 
the greatest potential to still display a treatment effect; the DE+O3 combination could potentially 
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have a synergistic effect as compared to the single DE or O3 exposures and create a greater 
chance having an increase in both pro- and anti- inflammatory cytokines (Huang et al., 2012; 
Madden et al., 2014).  The literature has mixed results for DE exposures, O3 exposures, and any 
effect these exposure might have on changes in lymphocytes, monocytes and neutrophils 
differential and absolute cell counts.  As such, there were no pre-conceived Pre/Post/Follow-up 
exposure hypotheses for these cells. 
The heatmap and the descriptive statistics show a heterogeneous effect by the respective 
treatments for the subjects, as it is evident by the fact that there are two different “groups” of 
subjects for 6 of the 10 cytokines across all exposures and days.  There are also individual results 
from each exposure, as evidenced by the non-uniform change in the standard error (Table 3.2) 
and the range of responses in Figures 3.3 and 3.4.  These individual changes were expected 
based on previous research, but the partitioning of the two “groups” was unexpected.  The 
investigation of which personal factors (BMI, age, race, etc.) contribute to this grouping is 
beyond the scope of this paper, but it is well known that gender can play an important role in the 
response to environmental contaminants (Setlow et al., 1998).  As such, the differences between 
male and female responses to the respective exposures were investigated, but the results were 
inconclusive based on the low number of female participants.  All four of the females were in the 
group with higher concentrations of IL-2, IL-12p70, IL-13 and IFN- γ, (as seen in Figure 3.2) but 
there was not enough statistical power to detect a difference between the group of 4 
females/4males and the other group of 7 males.  In addition, previous research shows genotypic 
associations (most commonly with GSTM1 +/- status) with proposed differential responses to 
O3-only exposures (Alexis et al., 2009; Gilliland et al., 2002).  4 of the 9 GSTM1- participants 
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were in the group with the higher concentrations of IL-2, IL-12p70, IL-13 and IFN- γ, but similar 
to the gender investigation, the results were inconclusive.    
3.4.1 Pre, Post and Follow-up Trends 
 
The results from the Day 1 analysis are contrary to the expectations.  The statistically 
significant “Pre” to “Post” decreases for IL-5 and IFN-γ for the clean “exposure” were 
unanticipated.  This change is most likely a bi-product of the incremental exercise on the 
recumbent bike and/or a circadian cycle variation.  This potential effect from the exercise is also 
present on Day 1 of the DE and DE+O3 co-exposures, and to some degree the O3 exposure, 
where IL-5 has a moderately significant “Pre” to “Post” decrease.  Given past results, it was also 
expected that the pro-inflammatory cytokines would increase following the DE-only and O3-only 
exposures but the majority of the cytokines had “Post” concentrations that were lower than the 
“Pre” concentrations.  Most of these relationships were not statistically significant, but the 
decreasing trend for the pro- and anti- inflammatory cytokines was unexpected. 
Unlike the results from the other three exposures, the Day 1 DE+O3 exposure suppressed 
both IL-12p70 and TNF-α production.  The trend for this type of suppression of an inflammatory 
response has been seen in DE-only and O3-only exposures, but at higher exposure levels and in 
different biological media (Bosson et al., 2009; Xu et al., 2013).  The results in this study are the 
first time that this type of inflammatory response has been seen for a “mixed” exposure and there 
are a few hypothetical reasons behind this suppression.  IL-12 is primarily produced by 
macrophages and as such, these cells are the most likely candidates for the production of IL-12 
given that this study uses an inhalation exposure.  Previous research shows that macrophages 
phagocytize DE particles (DEP), which then influences inflammation (Yang et al., 2001; Saito et 
al., 2002; Sawyer et al., 2010).  In this study, either the DE+O3 combination is limiting the 
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ability of the macrophages to phagocytize the DEP, or the co-exposure is limiting the 
differentiation of monocytes into macrophages in the epithelial lining of the lung tissue.  In either 
case, the production of IL-12 is limited by the exposure.  IL-12 is also known to be precursor 
and/or stimulating factor for the production TNF-α as well as the recruitment and differentiation 
of both Th1 and Th2 cells (Chung and Barnes, 1999).  Thus, the lack of IL-12 expression could 
play a role in the lack of TNF-α expression as well as some of the other cytokines that have Th 
cells as their progenitor cell. 
With a few exceptions, the Day 2 follow-up results are unremarkable when compared to 
the Day 1 results as most of the cytokines that were influenced by the Day 1 exposure return to 
their “pre” exposure levels.  IL-4 in the clean treatment does display an increase in expression 
22-hours after the exposure, which is the opposite of the trend seen on Day 1, but this can most 
likely be attributed to the exercise.  IL-2 in the O3 exposure is still significantly less than the 
“Pre” sample.  This result is one of the few times that this type of suppression has been shown 
following an O3 exposure. The DE+O3 co-exposure displays the most striking follow-up results 
with both IFN-γ and TNF-α still being suppressed.  The result for IFN-γ is most likely a 
combination of the exercise effect, as seen in the clean treatment, and the addition of the 
suppressive nature on the innate immune system from the DE+O3 exposure, which was discussed 
above for IL-12 and TNF-α.   
 
3.4.2 TNF-α 
 
The major contrast between the clean “control” and the other three exposures is the 
change in the expression of TNF-α.  This is an expected result as TNF-α is a known pro-
inflammatory cytokine and is one of the initial cytokines to be released by macrophages and Th1 
cells upon perturbation. However, the statistically significant decreases in TNF-α for the Day 1 
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DE and DE+O3 exposures were unexpected.  Figure 3.5 shows that the DE exposure has a 
statistically significant decrease (p<0.0001) in TNF-α following the 2-hour DE exposure but did 
recover to pre-exposure levels by the time the follow-up samples were taken.  The DE+O3 graph 
on the right side of Figure 3.5 shows that the “Pre” to “Post” difference is significant (p<0.0003), 
and there are two moderately significant results for the Pre-to-Follow-up and Post-to-Follow-up 
comparisons.  Given this, the combination of the DE and the O3 seems to have a synergistic 
effect on the exposure and resulting human response, and the direction of the result is an across-
the-board significant decrease in TNF-α expression. 
As mentioned earlier, a few human-based studies have examined the relationship between 
TNF-α expression and DE or O3 exposure.  The results for these studies are mixed with some 
showing increased expression, a few with decreased expression, and some with no change at all 
(Alexis et al., 2010; Devlin et al., 2012; Holgate et al., 2003; Törnqvist et al., 2007; Xu et al., 
2013).  In vivo murine studies have also concluded that O3 exposure can cause a suppression of 
TNF-α after an acute dosing regimen.  Recently, Oakes et al. 2013, showed that male C57B/L6 
mice exposed for 3 hours to an inhalation dose of 2 ppm of O3 had a statistical decrease in TNF-
α expression when compared to the control.  They note that their study, “used a high 
concentration of O3” but that, “exposure to 2 ppm of O3 in a rodent was shown to be comparable 
to 0.2 ppm of O3 in a susceptible human subject” (Hatch et al., 1994; Oakes et al., 2013).  The 
present study has similar exposure metrics (0.3 ppm for 2 hours) and while the DE exposure 
showed a significant suppression of TNF-α the O3 exposure only showed a moderate 
suppression.  Our results for these two exposures are comparable to the current literature, but no 
studies that have examined relationship between a DE+O3 co-exposure and TNF-α expression.  
Here we have shown for the first time that a DE+O3 inhalation co-exposure suppresses the 
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production of TNF-α, and the Day 1 exposure could be a primer for a more involved response on 
Day 2.   
 
3.4.3 White Blood Cells and Correlations 
 
The literature has mixed results for the relationship between WBCs and exposures to DE 
and O3, while to our knowledge there are no DE+O3 co-exposure results.  As seen in Table 3.3, 
the “Pre” WBC cell count percentages are equivalent across the four exposures but have varying 
“Post” changes based on the individual exposure. Changes in the pre-exposure to post-exposure 
WBC percentages following the clean arm can potentially be attributed to the incremental 
exercise, a similar result to the relationship between the clean arm and the cytokines IL-5 and 
IFN-γ.  There were also Pre vs. Post statistical differences in the DE, O3, and DE+O3 exposures, 
but the magnitude of the differences increased when comparing the DE and DE+O3 exposures to 
the clean treatment.  The magnitude of this change, when compared to the clean exposure (the 
other monocyte decrease), indicates that the combination of the DE and O3 are contributory 
factors.  While it could be argued that these relationships are no different than those observed for 
the clean exposure, the DE+O3 Pre-to-Follow-up comparisons show, for the first time, that there 
is an exposure effect.  
Interestingly, the percent changes have less statistically significant Pre/Post and 
Pre/Follow-up comparisons than the absolute cell count comparisons.  These differences 
demonstrate the shifting immune system dynamics at work related for the specific exposures.  
For example, the DE+O3 exposure has Pre to Post increasing PMN percentages as well as 
absolute counts, but the absolute lymphocyte counts do not change while the absolute monocyte 
counts decrease (though not significantly).  The percentage decreases for the lymphocytes and 
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monocytes is not due to decreasing overall numbers but the recruitment (and increasing 
numbers) of PMNs into the peripheral blood following the DE+O3 exposure.       
Correlations between the WBCs and the cytokines were only investigated for the DE+O3 
co-exposure given the lack of statistical relationships between the exposure and the 
cytokine/WBC expression for the other three treatments.  The Post/Post comparison between 
IFN-γ and the lymphocytes displays a strong negative correlation while the neutrophils display a 
strong positive correlation with IFN-γ.  IFN-γ is primarily produced by lymphocytes and the 
expectation should be that there is a positive correlation between these two, however we see the 
opposite.  This result could be time-related where perfusion from the site of inflammation for the 
cytokines into the peripheral blood is most likely delayed compared to the increase/decrease of 
WBC production.  However, there were no other time comparisons (i.e. Pre/Post, Post/Follow-
up, etc.) that had statistically significant positive or negative correlations between any of the 
WBCs and IFN-γ.  
Finally, the Post/Post and Follow-up/Follow-up anti-correlation between the monocytes 
and TNF-α is opposite of what would be expected; the peripheral monocyte percentages should 
be positively correlated with the expression of TNF-α.  The results from Tables 3.2 and 3.3 show 
that the mean TNF-α concentrations and monocyte percentages decrease following the DE+O3 
exposure, but on an individual basis the monocyte counts increase as TNF-α decreases.  One 
conclusion from these results is that there is a time-related explanation similar to that for IFN-γ, 
however the exposure could also be causing a relative increase in the expression of the 
monocytes but a relative suppression of TNF-α.  While either could be the case, solidifying this 
association and the relationships between IFN-γ, PMNs, and lymphocytes require further 
investigation. 
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3.5 Conclusion 
These results are important because they show, for the first time in humans, that a 
mixture of DE and O3 can induce a suppression of some of the communication proteins in the 
immune system that are involved with an inflammatory response. These results also show that 
the exposure has an effect on the circulating WBCs.  Not surprisingly, the O3-only and DE-only 
results have individual treatment related results, however it is the combination of these two that 
creates the synergistic relationship and subsequent results exhibited in the DE+O3 co-exposure.  
Given that the DE+O3 exposure presents the majority of the exposure-related effects for both the 
inflammatory cytokines and the WBCs, there is likely a physicochemical change occurring that 
induces the differential physiological response after inhalation when compared to the DE-only or 
O3-only exposures.  Madden et al. 2014, characterized the exposure chamber pollutants used in 
this analysis and their results show that the DE and DE+O3 exposure particle sizes (median size: 
0.200±0.007μm) are the same, thus concluding that the location of particle deposition in the lung 
should be similar.  The O3 concentrations for the O3 and DE+O3 exposures also remain the same 
(0.30ppm).  However, the NO:NO2 ratio during the DE+O3 exposure is 0.03ppm:1.72ppm, 
which is the inverse of the ratio seen in the DE exposure (1.58ppm:0.16ppm, NO:NO2, 
respectively).  The difference in ratios is the only variation seen in the environmental exposure 
measurements, and thus is most likely responsible for the increased responses seen in the DE+O3 
exposure. 
The follow-up results for the DE+O3 exposure also indicate that this combination has the 
ability to have a “priming” effect on the innate immune system, as evidenced by the statistically 
significant WBC and cytokine results 22-hour after the exposure.  While the investigation into 
any statistical relationships between the exposures, cytokines, and WBCs requires further study, 
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there are some strong correlations between the cytokines and WBCs that can be attributed to the 
DE+O3 interaction.  Finally, we recognize that our results come from circulating blood and not 
from pulmonary or upper airway tissue.  Samples from these locations would presumably give a 
more direct relationship between inhalation exposure and response.  In all likelihood, there are 
additional variables that are influencing the variability in these results, however, the initial 
results from the central compartment (blood) are encouraging and indicate an overall systemic 
effect. 
 
 74
CHAPTER 4 
 
Co-exposure to Diesel and Ozone Modifies Inflammatory Cytokine Expression, Blood 
Pressure, and Lung Function 
 
(Stiegel MA, Pleil JD, Sobus JR, Stevens T, and Madden MC. Co-exposure to diesel and ozone 
modifies inflammatory cytokine expression, blood pressure, and lung function. 2014, in 
preparation) 
   
4.1 Introduction 
Associations between outdoor air pollution and human health effects have been studied 
extensively, with special attention on particulate matter (PM) and gas phase pollutants due to 
their (mostly) anthropogenic origination and health impacts (Brook et al., 2009; Brook et al., 
2014; Dong et al., 2013; Fariss et al., 2013; Holgate et al., 2003). Diesel exhaust (DE) emissions 
are one of the most prevalent contributors to PM pollution and research has shown that DE 
exposure causes respiratory irritation, cardiovascular inflammation, and a host of other 
pulmonary-related health effects (Holgate et al., 2003; Madden et al., 2014; Törnqvist et al. 
2007).  Ozone (O3) is one of the most studied gas phase pollutants given it’s environmental 
prevalence, known reactivity within the body, as well as it’s relation to a variety of 
cardiovascular health effects (Barath et al., 2013; Devlin et al., 2012; Kim et al., 2011; Tank et 
al., 2011).  Epidemiological studies have also shown associations between DE and O3 exposures, 
disease progression, and potential mortality (Morishita et al., 2014; Shan et al., 2014).   
While much research shows the relationship between DE and O3 exposures and health 
effects, fewer studies attempt to clarify the biological pathways and mechanisms from the 
 75
exposure to the resulting health effect(s).  It has been proposed that an inflammatory response is 
a key-initiating event that creates a cascade of events toward a health effect (Bautista et al., 2005; 
Bhagat et al., 1997; Margretardottir et al., 2009;).  Th1 and Th2 cytokines have been studied as 
biomarkers of inflammation and the expression of specific cytokines is indicative of an immune 
response to an exogenous stressor.  As such, controlled inhalation exposures to either DE or O3 
have been used to investigate inflammatory cytokine responses and resultant changes in health 
(Ghanem et al., 2007; Xu et al., 2013).  Lung function changes are the most studied health effect, 
but exacerbation of existing pulmonary conditions (i.e. asthma and COPD), changes in heart rate 
variability, and variations in blood pressure have also been examined (Alexis et al., 2010; Devlin 
et al., 2012; Törnqvist et al. 2007).   
Morishita et al 2014, recently showed an association between exposure to PM2.5-10 and 
modifications in systolic blood pressure for 32 healthy human volunteers following a controlled 
2-hour exposure to concentrated ambient coarse PM.  Holgate et al. 2003 and Törnqvist et al. 
2007, did not investigate blood pressure changes but have demonstrated relationships between 
DE exposure and inflammation.  Barath et al. 2013, studied controlled O3 exposures (at 300ppb x 
75minutes) on 36 healthy young men, and found no associations between the exposure and 
modifications in either the systolic or the diastolic blood pressure.  On the other hand, Alexis et 
al. 2010 and Devlin et al. 2012, have shown that controlled O3 exposures do have a resulting 
inflammatory response.  Most recently, Madden et al. 2014 established a relationship between 
DE and O3 through the use of a series of controlled DE+O3 co-exposure chamber studies that 
demonstrates a synergistic effect on lung function changes following the combined exposure 
versus individual exposure to DE or O3. Finally, Stiegel et al. 2014 has shown a similar 
synergistic relationship between DE+O3 co-exposure and an inflammatory response. 
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These studies demonstrate the individual relationships between DE, O3, and DE+O3 
exposures, lung function modifications and blood pressure changes, but there are no attempts to 
investigate connections between the measured outcome variables (i.e. inflammation and the 
health measures), especially for combined DE+O3 exposures. The DE+O3 exposures are relevant 
to a “real-world” environmental exposure given the fact that an environmental exposure will 
almost always be a mixture of contaminants.  This current study will investigate correlations 
between inflammation, lung function, and blood pressure, with a highly-controlled 
environmental chamber study.  Based on previous research, we expect strong relationships 
between the inflammatory cytokines and lung function following the O3 and DE+O3 exposures, 
but no expectation of any relationships between the cytokines and blood pressure measurements.  
 
4.2 Methods 
4.2.1 Study Design 
The study population and exposure scenario is detailed in Madden et al. 2014, but, all 
participants were non-smoking, healthy young adult volunteers that had to be able to exercise for 
4, 15 minute, increments over a 2-hour time frame on a recumbent bike.  They also had to be 
willing to discontinue use of non-steroidal anti-inflammatory drugs, vitamin C, and vitamin E.  
Table 4.1 characterizes the 15 healthy human volunteers that participated in the study.  The 
majority of the participants are males, 9/15 are GSTM1+, and the average female BMI was 
greater than the average male BMI.  
Table 4.1: Demographics of Study Participants 
Gender Agea BMIb GSTM1c 
Male (n=11) 27.3 (24.4-30.5) 26.5 (24.7-28.3) 6+/4-/1nd
Female (n=4) 26.2 (22.9-29.9) 30.7 (21.7-39.7) 3+/1- 
ageometric mean (GM) and 95% confidence interval of the GM 
bmean (µ) and 95% confidence interval of the µ 
cGSTM1 genotype status (+ = positive, - = null, nd=no determination) 
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This study was designed as a random-crossover double-blind study with four exposure 
arms, with each arm being separated by approximately 2 weeks.  Volunteers were exposed in an 
environmentally controlled exposure chamber at the US EPA Human Studies Facility in Chapel 
Hill, NC to filtered air, DE (300 μg/m3), O3 (0.3 ppm), or a combination of DE and O3 for 2 
hours (IRB Study #: 09-1344).   
Whole blood was collected before and directly after each exposure arm in 10mL EDTA 
Vacutainer® (Product Number: 368589, Becton, Dickinson and Company, Franklin Lakes, New 
Jersey) collection tubes, centrifuged, aliquotted, and frozen at ≤-80°C until analysis.  The plasma 
fraction from the whole blood samples were analyzed using Human Th1/Th2 10-plex Ultra-
Sensitive Kits and a Meso Scale Discovery (MSD) SECTOR Imager 2400 (Meso Scale 
Discovery, Gaithersburg, MD) for the following cytokines: interleukins (IL) 1β, 2, 4, 5, 8, 10, 
12p70 and 13, IFN-γ, and TNF-α.  GSTM1 status was determined from isolated peripheral white 
blood cell DNA using QIAamp DNA real-time polymerase chain reaction Mini Kits (Qiagen 
Inc., Valencia, CA) (Kim, Gilliland).  Forced exhaled volume in 1 second (FEV1) and forced 
vital capacity (FVC) were measured using a 10.2L dry seal digital spirometer (SensorMedics, 
Model #1022, Palm Springs, CA) (Madden et al., 2014). 
4.2.2 Statistical Analysis 
Lung function measurements, blood pressure measurements, and cytokine concentrations 
for each exposure arm were tested for normality using Shapiro-Wilks tests (PROC 
UNIVARIATE, SAS statistical software package version 9.3, SAS institute, Cary, NC).  FEV1, 
FVC, and the systolic/diastolic blood pressure measurements were normally distributed.  Right-
skewed cytokine data was natural log-transformed before statistical analysis to accommodate 
assumptions of normality.  Pre-exposure to post-exposure cytokine concentration differences, 
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lung function changes, and blood pressure changes were investigated using paired student t-tests 
(Madden et al., 2014; Stiegel et al., 2014; Stevens et al., 2014a and 2014b).  A p-value <0.05 was 
considered statistically significant. 
Linear mixed-effect models (PROC MIXED, SAS) and restricted maximum likelihood 
estimates of variance components were used to calculate estimated intraclass correlation 
coefficients (ߩො௛ሻ for each cytokine/vital measurement and each exposure using the following 
equation (Rappaport and Kupper, 2008): 
ߩො௛ = ఙෝ್ೊ೓
మ
ఙෝ್ೊ೓
మ ାఙෝೢೊ೓మ
 where h=biological measurement (cytokine, FEV1, etc.), ߪො௕௒ଶ =estimated total 
between-person variance, and ߪො௪௒ଶ =estimated total within-person variance.  Linear mixed-effect 
models were also used to examine exposure-response differences by GSTM1 genotype. 
Post/Pre exposure ratios for each exposure arm and biological measurement were 
calculated.  These ratios were used for Spearman correlation coefficient calculations (PROC 
COR, SAS) and for graphical comparisons examining pre-to-post percentage changes for any 
statistically significant correlations.  GraphPad (GraphPad Prism version 6.0, GraphPad 
Software, La Jolla, CA) and Microsoft Excel (Microsoft Excel for Mac 2011, Microsoft, 
Redmond, WA) were used for graphical representations. 
 
4.3 Results 
4.3.1 Summary Statistics 
Table 4.2 summarizes the blood pressure and lung function measurements from the four 
exposure arms (Madden et al., 2014; Stevens et al., 2014a and 2014b).  The descriptive statistics 
are shown as a reference for the exposure-related health endpoints used in the cytokine 
comparisons. 
Table 4.2: Baseline and Post-Exposure Blood Pressure and Lung Function Measurements* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* data from Madden et al., 2014; Stevens et al., 2014a and 2014b, mean(SEM), “Total”:n=15, “GSTM1+”:n=9, “GSTM1-”:n=5, FEV1=forced exhaled volume   
in 1 second(Liters/1 second), FVC=forced vital capacity(Liters), SBP and DBP in mm Hg 
 
 
 
 
  Exposure 
  Air DE O3 DE+O3 
  Pre Post Pre Post Pre Post Pre Post 
SBP Total 117(1.99) 119(2.54) 118(1.50) 117(2.76) 115(1.88) 114(2.31) 118(2.23) 111(2.47) 
GSTM1+ 113(2.62) 115(3.60) 115(1.75) 116(4.37) 113(2.82) 112(2.85) 116(2.44) 109(3.21) 
GSTM1- 122(1.20) 124(2.58) 122(2.80) 116(2.89) 118(2.29) 120(3.79) 123(4.46) 116(4.41) 
DBP Total 73.3(1.80) 72.1(3.12) 73.9(1.52) 72.1(2.27) 70.2(1.87) 66.7(2.00) 72.9(1.93) 70.7(2.02) 
GSTM1+ 72.4(2.09) 69.7(3.38) 74.0(2.45) 71.7(1.84) 69.7(2.46) 66.1(1.65) 72.1(2.04) 67.7(2.01) 
GSTM1- 76.8(3.26) 76.2(7.36) 74.4(1.29) 71.6(6.31) 72.6(3.28) 67.2(5.60) 76.2(4.14) 77.2(3.56) 
FEV1 Total 4.35(0.236) 4.40(0.227) 4.37(0.243) 4.41(0.247) 4.39(0.252) 4.00(0.265) 4.37(0.246) 3.60(0.253)
GSTM1+ 4.21(0.315) 4.27(0.296) 4.24(0.319) 4.29(0.326) 4.25(0.324) 3.74(0.337) 4.24(0.314) 3.41(0.378)
GSTM1- 4.45(0.439) 4.49(0.439) 4.49(0.472) 4.45(0.464) 4.46(0.488) 4.29(0.475) 4.46(0.491) 3.77(0.321)
FVC Total 5.35(0.310) 5.37(0.305) 5.32(0.313) 5.33(0.307) 5.36(0.313) 4.90(0.304) 5.27(0.334) 4.64(0.340)
GSTM1+ 5.14(0.370) 5.18(0.354) 5.13(0.365) 5.11(0.340) 5.18(0.373) 4.67(0.367) 5.02(0.392) 4.20(0.348)
GSTM1- 5.52(0.663) 5.53(0.673) 5.48(0.696) 5.50(0.699) 5.43(0.667) 5.06(0.607) 5.48(0.707) 5.14(0.721)79
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Across all exposures, the “pre” blood pressure measurements ranged from a group 
minimum of 98/58mm Hg to a group maximum of 138/91mm Hg, with an average of 
117/72.6mm Hg.  The group minimum post-exposure BP across all exposures was less than the 
group minimum “pre” at 89/51mm Hg, the group maximum was similar to the “pre” at 
137/95mm Hg and the average was 116/70.4mm Hg.  The “pre” FEV1 and FVC lung function 
measures ranged from 3.00-5.94(μ=4.32) and 3.50-7.14(μ=5.32), respectively.  Both the “post” 
FEV1 and “post” FVC measurements had a wider range of responses than the “pre” measures 
varying (min. to max.) from 1.84-5.89(μ=4.10) for FEV1 and from 2.94-7.17(μ=5.06) for FVC.  
There were no statistically significant changes in any of the measurements for the control arm or 
the DE exposure arm.  Results from the O3 exposure showed statistically significant decreases in 
both lung function measurements following exposure, but there were no changes in either the 
systolic or diastolic blood pressure.  The DE+O3 exposure arm had significant Pre to Post 
decreases for the systolic blood pressure, FEV1, and FVC.  For all exposures, when stratified by 
the GSTM1 genotype, the relative responses were not different from one another. 
As described in more detail in Stiegel et al. 2014, but summarized here, Table 4.3 shows 
the statistically significant results from the cytokine analysis following the three exposure arms 
(DE, O3 and DE+O3) and the control (i.e. clean).  All statistically significant results were pre-
exposure to post-exposure decreases.  IL-5 and IFN-γ had a significant decrease following the 
clean air arm and this trend appeared in both the DE and DE+O3, leading to the conclusion this 
“effect” was most likely associated with incremental exercise.   
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Table 4.3: Summary of Statistically Significant Day 1 Pre-to-Post Exposure Results for Selected 
Cytokines* 
Exposure 
Clean DE O3 DE+O3 
IL-5 (0.011) IL-5 (0.02) IL-2 (0.006) IL-5 (0.05) 
IFN-γ (0.035) IFN-γ (0.05)   IL-12p70 (0.002) 
  TNF-α (<0.0001)   IFN-γ (0.003) 
         TNF-α (0.0003) 
*Stiegel et al. 2014, cytokine(p-value), all “post” results were significantly lower than the “pre” results 
 
The average percent change from baseline for IFN-γ has a decreasing tendency from -
14.1% for the clean arm to -17.2% and -24.4% for the DE and DE+O3 exposures, respectively.  
However, a subsequent analysis compared the Post/Pre relationships for IFN-γ across the clean, 
DE, and DE+O3 arms and showed no statistically significant difference between the clean arm 
and either the DE or DE+O3 exposures.  TNF-α, a Th1 pro-inflammatory cytokine, displayed a 
significant decrease in expression following the DE and DE+O3 exposures, with average 
decreases of –11.9% and -16.7%.  IL-12p70, also a Th1 pro-inflammatory cytokine, also had a 
statistically significant decrease following the DE+O3 exposure arm, averaging -14.4%.     
Figure 4.1, below, displays the post-to-pre measurement ratios for systolic and diastolic 
blood pressure, FEV1, FVC, and 7 inflammatory cytokines for the DE+O3 exposure (3/10 
cytokines had no statistically significant Pre-to-Post change for any of the four exposure arms 
and thus were omitted).  This figure shows that the systolic blood pressure, FEV1, FVC, IL-4, IL-
5, IL-12p70, IFN-γ, and TNF-α have median post-exposure decreases, IL-2 and IL-8 have 
median increases, and the diastolic BP has no change following the DE+O3 exposure.  The figure 
also shows that the three Th1 cytokines with statistically significant decreases (IL-12p70, IFN-γ, 
and TNF-α) are suppressed to a greater extent than the significant decrease shown by the one 
Th2 (IL-5) cytokine.  IL-2 and IL-8 have the greatest range in the post-pre ratio and generally, 
there is more variation for cytokine ratios as compared to the four health measurements. 
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Figure 4.1: Post/Pre DE+O3 Exposure Ratios for Blood Pressure, FEV1, FVC, and Th1/Th2 
Inflammatory Cytokines 
 
The boxes, above in Figure 1, display the median, upper 75%, and lower 25% of the range of post/pre exposure 
ratios while the bars display the upper 97.5% and the lower 2.5% of the respective ratios.  The dotted line at “1”, on 
the y-axis, indicates the ratio where the Pre-exposure concentration is equal to the Post-exposure concentration.  A 
statistically significant result above or below “1” indicates that there has been an increase/decrease in the 
concentration for that respective measurement following the 2-hour exposure period. *p<0.05, data previously 
published by a: Stevens et al. 2014a and 2014b, b: Madden et al. 2014, c: Stiegel et al. 2014  
 
4.3.2 Correlations 
 
Table 4.4 displays the estimated intra-class correlation coefficientsሺρො௛ሻ for the respective 
exposures.  Here, the results for the clean arm represent the distribution of variance for the 
respective health measures and cytokines for un-exposed people.  Across all exposures, the SBP 
results show that the DE and DE+O3 arms migrate away from the variance being between-people 
and toward more within-person variance.  This shift toward more within-person variance 
demonstrates that the response to the exposure(s) is seemingly independent of the individual.  In 
addition, across all exposures, the lung function results show that the majority of the variance is 
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between-person (average ρො௛=0.852 and 0.932 for FEV1 and FVC, respectively).  These clean 
results show that the majority of the measurements have more between-person variance than 
within-person variance; under no external pressure (exposure) these results demonstrate the 
majority of the variance is dependent on the individual (i.e. the individual responses in the group 
are different from one another).  The DE results have similar ICC estimates to the clean arm, 
except the systolic blood pressure has more within-person variance and IL-8 switches to more 
between-person variance.  The O3 exposure is also very similar to the filter air exposure with IL-
4 being the one exception.  The DE+O3 exhibits the most changes when compared to the clean 
arm.  The ρො௛ for SBP is solely within-person, FEV1 trends toward a split of the variance within-
person and between-person, and IL-4 switches to more between-person variance.  
Table 4.4: Estimated Intraclass Correlation Coefficients ሺρො௛ሻ for the Four Exposures* 
Clean DE O3 DE+O3 
Systolic BP 0.730 0.427 0.644 0.136 
Diastolic BP 0.387 0.187 0.229 0.435 
FEV1 0.927 0.994 0.869 0.620 
FVC 0.999 0.996 0.896 0.835 
IL-2 0.780 0.716 0.871 0.640 
IL-4 0.413 0.563 0.983 0.826 
IL-5 0.843 0.722 0.913 0.744 
IL-8 0.139 0.843 0.429 0.271 
IL-12p70 0.895 0.633 0.950 0.889 
IFN-γ 0.982 0.934 0.924 0.754 
TNF-α 0.902 0.913 0.744 0.683 
*ρො௛ ranges from 0-1, where “0” is only within-person variance, “0.5” is an equal division between within and 
between person variance, and “1” is only between-person variance  
 
Results from the ICC estimates indicate that the variation in responses to the exposures 
deserves investigation on the individual level.  Table 4.5 describes the number of individuals 
with a 10% increase or 10% decrease in their individual response for the respective exposure 
versus their individual response during the clean arm.  Generally, the majority of measurements 
are “low” as compared to “high”.  The DE exposure results have no lung function measurements 
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where the individuals are outside the ±10% window, while the O3 results show ~1/3 of the 
participants are have more than a 10% decrease when compared to their respective clean 
response, and the DE+O3 exposure has ~2/3 of the participants that have more than a 10% 
decrease.  There are fewer subjects in the O3 and DE+O3 exposures that have SBP or DBP 
measurements outside the ±10% window as compared to the number of subjects outside this 
window for the lung function measurements, demonstrating that there is slightly less of a 
response on the individual level following these exposures.  The cytokines have wide variations 
in the individual responses to the exposures, as seen in the fact that the majority of the 
participants are either higher or lower than their respective clean arm response, across all 
exposures.          
Table 4.5: Individual Responses by Exposure in Comparison to the Clean Arm*  
DE O3 DE+ O3 
Low High Low High Low High 
FEV1 0 0 6 0 11 0 
FVC 0 0 6 0 8 0 
SBP 3 1 1 1 6 0 
DBP 1 2 4 3 6 2 
IL-2 9 3 10 2 6 4 
IL-4 6 7 2 9 3 8 
IL-5 4 6 5 4 7 6 
IL-8 3 5 4 6 5 9 
IL-12 10 5 9 2 10 3 
IFN- γ 7 6 5 7 6 5 
TNF- α 6 0 8 3 10 1 
*the number in a respective box is the number of participants, out of the total (n=15), that had a post-exposure to 
pre-exposure ratio(Post/Pre) that was 10% lower(“Low”) or 10% higher(“High”) than the same Post/Pre response 
for that individual and that measurement for the “Clean” arm 
 
Spearman correlation results for the Post/Pre exposure-responses between the 7 
cytokines, blood pressure measurements, and lung function results for each exposure arm are 
displayed in Table 4.6.  Results investigating within-cytokine or within-health measurement 
correlations are not presented in Table 4.6.  There were no significant correlations between SBP 
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and DBP or between any of the lung function measures and the blood pressure measurements for 
the DE, O3, and DE+O3 exposure arms.  There were significant positive correlations between 
FEV1 and FVC for the O3 and DE+O3 exposures.  The three exposure arms displayed a 
noteworthy difference between the two DE-associated exposures and the O3 exposure.  The DE 
exposure had a negative correlation between DBP and IL-12p70, and the DE+O3 displayed 
negative correlations between SBP and both IL-8 and IFN-γ.  These three cytokines are Th1 
cytokines (IL-8, IL-12p70, and IFN-γ) and are solely, and negatively, associated with the blood 
pressure measurements.  Conversely, the O3 exposure has no correlations between any Th1 
cytokines and blood pressure measurements, but does display a statistically significant negative 
correlation between a Th2 cytokine (IL-5) and DBP.  The O3 exposure also had positive 
correlations with both of the lung function measurements and IFN-γ.      
Table 4.6: Statistically Significant Correlations between Blood Pressure, FEV1, FVC, and 
Cytokines, by Exposure 
Exposure 
Clean DE O3 DE+O3 
Systolic 
BP - - - 
IL-8 [-0.675(0.0058)] 
IFN-γ [-0.729(0.002)] 
Diastolic 
BP - 
IL-12p70       
[-0.529(0.045)] 
IL-5            
[-0.546(0.038)] - 
FEV1 - - IFN-γ [0.843(<0.0001)] - 
FVC - - IFN-γ 
[0.711(0.003)] 
- 
BP=blood pressure, FEV1=forced exhaled volume in 1 second, FVC=forced vital capacity [Spearman rho(p-value)] 
 
Figure 4.2 displays the relationship between the Post/Pre exposure ratios following the 
DE+O3 for the systolic blood pressure and IL-8.  Here, there are three important results to note.  
One, when the pre-exposure SBP is greater than the post-exposure SBP, the inverse is true for 
the cytokine concentration (i.e. the pre-exposure IL-8 concentration is less than the post IL-8 
concentration), and vice-versa at the other end of the distribution.  Two, there is a centralization 
of 4 of the GSTM1- subjects around 1,1, with the 9 GSTM1+ subjects having more variation in 
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their overall responses (seen at the extremes of the blood pressure/IL-8 comparison).  Three, 
Figure 4.2 shows that only 1 subject has both a SBP and IL-8 exposure ratio less than “1”; the 
majority of the subjects have a post-exposure IL-8 concentration that is greater than the pre-
exposure concentration, but a post-exposure SBP measure that is less than the pre-exposure 
measure.  
Figure 4.2: Systolic Blood Pressure Post/Pre Exposure Ratio versus IL-8 Post/Pre Exposure 
Ratio for the DE+O3 Exposure 
 
Figure 4.2, above, displays the relationship between the Post/Pre IL-8 exposure ratio to the Post/Pre systolic blood 
pressure exposure ratio.  The “post” concentration for IL-8 increases as the “post” systolic blood pressure 
measurement decreases.   
 
Figure 4.3 is similar to Figure 4.2 in that it shows the same type of negative correlation 
for the DE+O3 and the systolic blood pressure, but in this case with IFN- γ.  The association 
between the SBP and IFN-γ is stronger (ρ=-0.729 vs ρ=-0.675), and more tightly grouped, than 
the SBP/IL-8 comparison.  The majority of the SBP/IFN-γ comparisons are less than, or very 
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close, to having both a SBP exposure ratio less than “1” and an IFN-γ exposure ratio less than 
“1”, meaning that the post-exposure measurements are lower than the pre-exposure 
measurements.  The GSTM1- subjects seem to have more of a 1:1 relationship between the SBP 
and IFN-γ when compared to the GSTM1+ subjects, but any difference in trend is hard to 
compare given the low number of GSTM1- participants.   
Figure 4.3: Systolic Blood Pressure Post/Pre Exposure Ratio versus IFN-γ Post/Pre Exposure 
Ratio for the DE+O3 Exposure  
 
Figure 4.3, above, displays the relationship between the Post/Pre IFN-γ exposure ratio to the Post/Pre systolic blood 
pressure exposure ratio.  The “post” concentration for IFN-γ increases as the “post” systolic blood pressure 
measurement decreases. 
 
4.4.3 Comparisons of Percent Change from Baseline  
 
Figures 4.4 and 4.5 investigate group changes from baseline for the O3 and the DE+O3 
exposures.  The cytokines and vital measurements in these figures were chosen based on the 
significant correlations in the respective exposure.  Figure 4.4 shows that there is a mean 
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decrease for each of the five measures which ranged from -4.27% to -10.3%.  The cytokines 
displayed more variation in response to the O3 exposure when compared to the diastolic BP, 
FEV1, or FVC.  The stratification of the measured responses into GSTM1-/+ shows that in every 
instance, except for DBP, the mean percent change following exposure for the GSTM1+ 
participants is greater than that for the GSTM1- participants.  There were no statistically 
significant differences between these two genotypes, however the GSTM1+ participants were 
close to having significantly different responses when compared to the GSTM1- participants for 
FEV1 and IFN-γ (p-values of 0.079 and 0.091 for FEV1 and IFN-γ, respectively).                
Figure 4.4: Percent Change from “Pre” Measurement following O3 Exposure* 
 
Figure 4.4 shows the mean and standard error of the mean(SEM) for the percent change (“post” vs. “pre”)   
following the O3 exposure.  The data is displayed as total, GSTM1+, and GSTM1-, with the one “no-determination” 
genotype omitted.  a,bThe “total” FEV1 and FVC have statistically significant decreases following the O3 exposure. 
FEV1 and IFN-γ response stratified by GSTM1 genotype shows that GSTM1+, for both metrics, has a close to 
statistically significant decrease (p-value of 0.079 and 0.091 for FEV1 and IFN-γ, respectively) when compared the 
GSTM1- genotype.  The dotted line at “0” on the x-axis indicates a 1:1 Pre:Post relationship.  *FVC and FEV1 data 
from Madden et al. 2014, diastolic blood pressure data from Stevens et al., 2014a and 2014b. 
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Figure 4.5 shows that there are mean decreases of -5.35% for SBP, -24.4% for IFN-γ, and 
a mean increase of +6.40% for IL-8 when compared to the baseline “pre” samples.  Like the O3 
exposure, the two cytokines displayed more variation in response when compared to the BP 
measurement.  The DE+O3 exposure results also exhibited similar responses after stratification 
into GSTM1-/+ genotypes; the mean percent change following exposure for the GSTM1+ 
participants is greater than that for the GSTM1- participants.  Finally, while there were no 
statistically significant differences between the two genotypes for the any of the three 
measurements, the GSTM1+ participants were close to having a significantly different response 
when compared to the GSTM1- participants for the change in IL-8 concentration following 
exposure (p=0.059).  
Figure 4.5: Percent Change from “Pre” Measurement following DE+O3 Exposure* 
 
*Figure 4.5 shows the mean and standard error of the mean(SEM) for the percent change (“post” vs. “pre”)   
following the DE+O3 exposure.  The data is displayed as total, GSTM1+, and GSTM1-, with the one “no-
determination” genotype omitted. The dotted line at “0” on the x-axis indicates a 1:1 Pre:Post relationship.  The 
systolic blood pressure and IFN-γ displayed statistically significant decreases following exposure (see Figure 1).  
aIL-8 response stratified by GSTM1 genotype shows that GSTM1+ has a close to statistically significant decrease 
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(p-value=0.059) when compared the GSTM1- genotype. Systolic blood pressure from Stevens et al., 2014a and 
2014b. 
   
 
4.4 Discussion 
This study examined associations between controlled acute exposures to DE, O3, and a 
DE+ O3 combination, inflammatory responses, lung function changes, and variations in blood 
pressure.  Previous research has already shown that the filtered air and DE exposure had no 
influence on FEV1, FVC, or the systolic or diastolic blood pressure (Madden et al., 2014, Stevens 
et al., 2014a and 2014b).  These studies also showed O3-derived lung function changes as well as 
DE+O3 lung function decrements and decreases in SBP (Madden et al., 2014, Stevens et al., 
2014a and 2014b).  Stiegel et al. 2014, demonstrated decreases in Th1-derived cytokines 
following the DE, O3, and DE+O3 exposures, with the DE+O3 exposure having the largest 
inflammatory response when compared to the other exposures.  Here, the interest lies in how the 
respective exposures influence the exposure-response outcome measurements on an individual or 
group level, and how these responses are correlated. 
The relationship between lung function and blood pressure has been studied extensively, 
mostly with respect to hypertension and potential adverse effects on lung function (Kamal et al., 
2009; Chae et al., 2001). The literature demonstrates mixed results, with various studies showing 
no relationship between lung function and blood pressure and some epidemiological studies 
showing inverse relationships between lung function and blood pressure (Wu et al., 1998).  The 
correlation results from this present study show that there is an independent relationship between 
the lung function results and the blood pressure results, and that this independent relationship is 
not influenced by any of the exposures.  While there was a statistically significant decrease in the 
lung function measurements and DBP following the O3 exposure, and significant decreases in 
lung function measures and SBP following the DE+O3 exposures, not all participants responded 
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in the same manner or to the same degree (i.e. subjects that started “high” did not necessarily end 
up “high” and those that started “low” did not necessarily end up “low”).  The initial hypotheses 
were that both blood pressure and lung function were more stable within persons than between 
persons.  If this were the case, it would be illustrated in the results by more between-person 
variation.   
The variance for the individual SBP responses shows that the DE and DE+O3 exposures 
have more within-person variance.  This same trend is not seen for the clean or O3 exposures.  
The SBP results for the clean and O3 arms demonstrate that the individual responses are 
independent of the group, thus leading to the conclusion that the DE particulate is influencing the 
manner in which the individuals respond to the exposure; the overall response for the DE and 
DE+O3 exposures is more of a “group” response than an individual response.  On the other hand, 
the intra-class correlations for the lung function measurements show that the responses were 
more stable within the individual, even when considering the exposure conditions.  The stability 
of the lung function results can be attributed to the fact that individual responses are closely 
related to demographics (BMI, gender, age, etc.), which led to less variation in the individual 
responses when compared to the group response.  Finally, the shift toward more between-person 
variance for the IL-4 measurements in the O3 and DE+O3 exposures shows that O3 potentially 
has more of an effect on the group as a whole, than the individual.        
Correlations between the inflammatory response and the health measurements were 
wholly dependent on the specific exposure.  Previous research has shown that increases in blood 
pressure are directly correlated with increases in inflammatory markers (Mirhafez et al., 2014; 
Schnabel et al., 2011).  The majority of these studies investigated the relationship between blood 
pressure and inflammatory markers on a case-control or cross-sectional basis, irrespective of an 
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exposure, and thus looked primarily at groups that already had “high” or “low” blood pressure 
(Bautista et al., 2005; Ghanem and Movahed, 2007; Margretardottir et al., 2009).  The primary 
conclusions were that hypertension and inflammation are correlated, but there were no 
indications that either inflammation or blood pressure initiated a response in the other respective 
measurement.  The volunteers for this study were healthy, having an average blood pressure of 
117/72.6 mm Hg, and thus would not be considered hypertensive or hypotensive.  The pre-
exposure lung function results from this study were also in the expected range for the given age, 
height, weight, and gender of the respective participants.  As such, any relationships between 
inflammatory markers, blood pressure, and lung function should be indicative of a response to 
the exposure.    
These results demonstrated a large difference between the Spearman correlation results 
for the DE+O3 and O3 exposures.   The DE+O3 had no statistically significant correlations with 
either of the lung function measurements, while the O3 exposure had strong positive correlations 
between the cytokine response and both FEV1 and FVC.  On the other hand, the DE+O3 
exposure had stronger negative correlations with the systolic blood pressure measurements.  IL-8 
and IFN-γ, the two cytokines in the DE+O3 exposure that were strongly correlated with SBP, are 
Th1-derived cytokines that are known to elicit phagocyte-dependent immune responses (Chung 
and Barnes, 1999).  IL-5, the one cytokine in the O3 exposure that has a significant correlation 
with DBP, is a Th2-derived cytokine, and Th2 cytokines are usually responsible for phagocyte-
independent immune responses (Chung and Barnes, 1999).  Given there was no particulate 
during the O3 exposure, the assumption is that the DE particulate component of the DE+O3 
exposure is modulating the expression of the Th1 cytokines and the blood pressure, and the 
correlation results show that this relationship is inversely related.  While previous research has 
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independently shown exposure-related suppression of Th1 cytokines and exposure-related 
suppression of the systolic blood pressure following the DE+O3 exposure, the conclusion here is 
that these two results are correlated but not predictive, or causative, of the one another (i.e. they 
could be behaving independently from each other). To our knowledge, this is the first controlled 
human-based exposure study that has demonstrated statistically significant correlations between 
decreases in systolic blood pressure and increases in IL-8 and IFN-γ following DE+O3 exposure.      
A lack of statistically significant correlations between any of the inflammatory cytokines 
and the lung function measurements is also important to note given the statistically significant 
decrease in FEV1, FVC, and the four different cytokines following the DE+O3 exposure.  The 
initial assumption, given those exposure-related results and research showing strong links 
between inflammation and lung function, was that there would be a statistically significant 
correlation between one or more of the cytokines and the lung function results.  However, this 
was not the case. There are a few hypothetical reasons why a correlation was absent.  As 
previously discussed in Stiegel et al. 2014b, the DE+O3 combination is suppressing the 
phagocytic immune response.  The O3, or the increase in NO2, is either inhibiting the macrophage 
from phagocytizing the particulate matter or limiting the recruitment or differentiation of 
macrophages in the epithelial lining of the lung tissue (Yang et al., 2001; Saito et al., 2002; 
Sawyer et al., 2010).  The results in the present study show that this inhibition is correlated with 
an increase in blood pressure, and there is potentially another mechanism (more closely related 
than the measured cytokines) that is driving the lung function results.  The significant exposure-
related responses for the cytokines could still be associated with lung function, however the 
time-dependent nature of the exposure in relation to the measurement(s) and biological sampling 
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most likely also played a part in the lack of correlations (i.e. the volunteers performed lung 
function testing, blood pressure measurements, and blood draws at relatively the same time). 
The GSTM1- polymorphism has been associated with sensitivity to O3 exposure and 
decreased lung function, and the increased production of cytokines in response to diesel particles 
instilled intranasally (Alexis et al., 2009; Gilliland et al., 2002; Gilliland et al., 2004; Yang et al., 
2008)).  As such, the statistically significant correlations in this study were examined by GSTM1 
genotype, and while there were no significant differences or changes in the correlations after the 
stratification, the results are noteworthy.  In general, the GSTM1- group had less of an exposure-
related response for all correlated health measurements and cytokines, but this group also had 
more variation around the respective response.  The increased variation and low number of 
volunteers with the GSTM1- polymorphism probably led to the lack of a significant difference 
between the two groups.  Given more GSTM1- participants, the variation would most likely 
trend toward the respective means and the current non-significant differences between the 
GSTM1+ and GSTM1- groups could become significant.       
4.6 Conclusions 
This study shows that the expression of IFN-γ following O3 exposure has a statistically 
significant positive correlation between both lung function measures, demonstrating that O3-
related modifications in FEV1 and FVC could be mechanistically related to the expression of 
IFN-γ.  The results also show that controlled acute exposure to DE+O3 creates SBP and lung 
function changes but these responses are independent of one another.  Inflammatory responses 
following DE+O3 exposure are not correlated with lung function but are correlated with changes 
in systolic blood pressure.  This is the first controlled human exposure study that has 
demonstrated statistically significant negative correlations between inflammation and SBP 
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following DE+O3 exposure.  These results suggest that the two Th1-derived cytokines (IL-8 and 
IFN-γ) could be facilitating the change in blood pressure, but further investigation into this 
relationship is warranted.  The study results also show that there is a statistically significant 
decrease for SBP following the DE+O3, but the individuals responded differently from one 
another.  Finally, the results showed that GSTM1 genotype appears to have a differential effect 
on the responses, but this analysis was underpowered and would require more study participants 
to fully clarify these differences.  
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CHAPTER 5 
Concluding Remarks and Observations 
The overall objective of this dissertation was to describe the relationships between 
controlled human exposures to DE, O3, and DE+O3, the human inflammatory pathway, and any 
cardiopulmonary health outcomes.  Inflammation was used as a parameter to describe the 
exposure-response-health effect relationship, as well as a parameter to link the exposure(s) to a 
biological pathway that is associated with disease.  The initial goals for the research were as 
follows: 
1. Develop and optimize a human Th1/Th2 Cytokine 10-Plex immunoassay and then apply 
this method to generate measurement distributions of inflammatory proteins in a group of 
human cohorts.   
2. Determine the difference in inflammatory cytokine expression for clean filtered air, DE 
(300 μg/m3), O3 (0.3 ppm), and a DE+O3 co-exposure. 
3. Determine whether inflammatory cytokine expression can be an indicator of a 
cardiopulmonary health outcome following exposure to the DE, O3, or DE+O3 exposure. 
The results in Chapter 2 optimized an immunochemistry method, which was then used for the 
identification of the 10 cytokines of interest in plasma, EBC, and urine from healthy human 
volunteers.  There were no unexpected outcomes in this stage of the research. 
The majority of the results from Chapter 3 were contrary to the expectations.  The initial 
assumption was that the pro-inflammatory cytokines would increase in concentration, as 
compared to the control exposure, following the three exposure conditions.  The DE+O3 co-
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exposure should have the greatest potential to have a significant increase in pro-inflammatory 
cytokine concentration.  However, the results demonstrated the opposite trend; the majority of 
the cytokines that had statistically significant changes following exposure had a suppression 
following the respective exposure.  The other initial assumption was that the Th2 cytokines 
would not be influenced by any of the exposures, but the opposite trend was seen as two of the 
Th2 cytokines demonstrated statistically significant changes.  We proposed that the DE, O3, and 
DE+O3 exposures had a greater effect on the Th1 cytokines, and the expression of Th2 cytokines 
could potentially be linked to this suppression of the Th1 cytokines.  We expected an increase in 
PMN concentration following the ozone exposure but the results showed for the first time that 
the DE+O3 co-exposure increases circulating PMN and that this increase is still exhibited 22 
hours after the end of the exposure (i.e. there is the potential to see a “priming” effect of the 
innate immune system that is directly related to the DE+O3 exposure).  Finally, we did not expect 
the decreases in monocyte concentrations following the DE+O3 exposure.  We proposed that the 
DE+O3 exposure not only had a direct impact on the monocyte concentration but also created the 
negative correlation between the monocytes and TNF-α.  The overall findings in Chapter 3 
suggest that ambient exposures to a mixture of DE and O3 could have an impact on the 
inflammatory pathway by influencing the expression of Th1/Th2 cytokines and WBCs. 
 The results from Chapter 4 produced unique contributions that describe the relationships 
between exposure to O3 or DE+O3, the resulting inflammation, and cardiopulmonary health 
outcomes.  The initial hypothesis was that inflammatory cytokines could be used as indicators of 
a cardiopulmonary health outcomes following exposure to the DE, O3, or DE+O3 exposure.  
Correlations between the cytokines and the health outcomes (FEV1, FVC, SBP, and DBP) 
demonstrated two important associations that were seen for the first time.  First, there were 
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strong positive correlations between IFN-γ and both lung function outcomes following the O3 
exposure. Second, there were strong negative correlations between the systolic blood pressure 
IL-8 and IFN-γ following the DE+O3 exposure.  These relationships with cytokines had never 
been described in the literature, and thus were new and unexpected findings.  The second, and 
potentially most important outcome from Chapter 4 was the heterogeneous response exhibited by 
the group following exposure to DE, O3, and DE+O3.  The a priori assumption was that the 
exposures would elicit a similar response from all volunteers.  The actual results revealed a wide 
range in cytokine expression and lung function outcomes.  Attempts made to elucidate 
underlying characteristics that explained this variance in response were inconclusive. The 
differential responses observed following the exposures are important to note because these 
participants were selected to represent nominally healthy adults and not part of a “susceptible” 
population.  Thus, truly susceptible individuals could have an even greater potential for adverse 
health impacts following ambient exposures to DE and O3. 
 
5.1 Cytokine Methods Development 
One of the main difficulties in determining an exposure-response relationship for an 
environmental exposure is the ability of the analytical method to measure baseline concentrations 
for the biomarkers of interest.  In the current exposure study, we needed background or “pre-
exposure” concentrations for the inflammatory cytokines to demonstrate a quantitative change 
following the scripted exposures.  The literature contains few comparison values for the 
cytokines of interest, and the majority of the 10 cytokines lacked “control” or “pre-exposure” 
values.   However, the absence of such data turned out to be beneficial in that it provided 
incentive for improving the state-of-the-art of cytokines measurements.  The existing reported 
methodological limits of detection were used as starting points for methods-development work; 
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the methods used in this study needed to provide an LOD of ~0.075 pg/mL to identify the 
cytokines of interest in the “control” samples (Jacobs et al., 2001; Matsunaga et al., 2006; 
Ostrowski et al., 1998).  This goal was ultimately achieved. 
The traditional analytical method used for cytokine analysis, enzyme-linked 
immunosorbent assay (ELISA), is known to have method-induced variation, primarily caused by 
a lack of specificity for an individual cytokine.  This variation can then influence the results by 
introducing an artificial “range” for the respective cytokine instead of giving the “true” 
concentration.   
The introduction of variance is even more prevalent near the limit of quantitation, which 
presented yet another issue for determining baseline concentrations.  Finally, traditional ELISA 
techniques are known to be specific not only for an individual protein, but also for the biological 
media from which the protein originates.  The methods used in this study needed to be able to 
address matrix interference issues that could be encountered while trying to simultaneously 
investigate the 10 cytokines in exhaled breath condensate, plasma, and urine.   
To overcome these problems, a method was needed that was sensitive enough for 
determine the concentrations for the 10 cytokines in our “pre-“ samples but was also specific 
enough to overcome the competitive-binding and matrix-interference issues that are known to 
exist in ELISAs.  The results from Chapter 2 demonstrated that the chosen method was robust 
enough to address the complexity of matrix inferences that are often seen when searching for the 
same biomarker in three different biological media and that the measured cytokine could be 
identified and quantified at ultra-trace levels (~0.05 pg/mL).  We have also shown that exhaled 
breath condensate samples and urine samples could potentially be used as alternate, and less 
invasive, sample medium for investigating the cytokines of interest.  Finally, we anticipate that 
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the results from Chapter 2 could be used as a template for future research study designs that have 
to balance a combination of sensitivity, specificity, and expense for the chosen analytical 
method.  
 
5.2 Inflammatory Response following Diesel Exhaust and Ozone Exposures  
 
The results from Chapter 3 demonstrated, for the first time, that a DE+O3 co-exposure 
induced a synergistic suppression of pro-inflammatory cytokines, which was contrary to what 
was expected.  Previous research revealed some pro-inflammatory cytokine increases following 
DE-only and O3-only exposures, so that expectation held for the present study, and we 
hypothesized that the DE+O3 combination would demonstrate a synergistic inflammatory 
increase.  Two studies previously demonstrated an inflammatory suppression for DE-only and 
O3-only exposures but both of these studies were at higher exposure levels and the inflammatory 
response was not measured in plasma but rather in lung lavage fluid (Bosson et al., 2009; Xu et 
al., 2013).  We proposed that the initiation of this suppression was influenced by the inability of 
the macrophages to phagocytize the DE particles, and that this inability was produced by the 
addition of O3.  We also proposed that the addition of the O3 caused a shift in the Th1/Th2 
balance, which could have attributed to the suppression of the Th1-specific cytokines.   
 Our second conclusion from these results demonstrated that the DE+O3 exposure could 
have a “priming” effect on the immune system resulting in an exaggerated response on 
consecutive exposure days.  The priming effect has direct relevance to environmental exposures 
wherein an individual could be exposed to low levels of these pollutants on consecutive days in 
the ambient environment without experiencing any overt health effects.  This continual exposure 
and resulting immune response could lead to a “suppressed” immune system, the inability to 
adequately respond to further insult, and the initiation of a more involved downstream health 
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response.  Immunosuppression following environmental exposures has been studied previously, 
with the consensus that suppression is potentially more harmful than a moderate increase in 
immune response (Glover-Kirkvliet, 1995; Rooney et al., 2012).  These results are of particular 
concern for susceptible populations (e.g. young, old, pre-disposed to asthmatic reactions, and 
existing cardiovascular illness) that already have “stressed” or underdeveloped immune systems, 
as this additional exposure-related stress could contribute to increased vulnerability and harm.  
 These results also show that there are strong correlations between the white blood cells of 
the immune system and cytokine expression.  While these results were expected, they 
demonstrated that cytokines in the peripheral blood could be used as potential indicators of in 
situ WBC changes in the lung following inhalation exposures.  However, the results are not 
completely predictive and more research would be needed to establish statistical relationships 
between the exposures, the cytokines, and the WBCs.  Finally, these results illustrated that there 
were individual as well as group responses to the exposures.  This outcome was unique because 
we expected everyone to have the same general response to the respective exposure condition, 
and thus led to further investigation of this outcome in Chapter 4.  In summary, these results 
demonstrated an overall systemic inflammatory exposure-response effect in the blood of healthy 
human volunteers for DE and O3 exposures and a synergistic inflammatory effect for the DE+O3 
exposure. 
 
5.3 Correlations between Diesel and Ozone Co-exposures and Cardiovascular Health 
Effects 
 
Chapter 4 investigated the relationship between the three exposures, the resulting 
inflammatory response, lung function responses, and blood pressure modifications.  Previous 
work demonstrated lung function decreases as well as decreases in systolic blood pressure 
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following the DE+O3 exposure (Madden et al., 2014; Stevens et al., 2014a and 2014b).  Our 
correlations illustrated independence between these two cardiovascular measures, which was not 
unique, as it has been shown that these two measurements usually act independently of one 
another, but the relationship between the inflammatory reaction and the health measures was 
noteworthy.  The initial assumption was that the lung function measurements and the pro-
inflammatory cytokines would be positively correlated given that both had statistically 
significant suppression following the exposures.   
However, there were no significant correlations exhibited by any of the cytokines and 
either of the lung function measurements for the co-exposure.  The DE-only exposure had the 
similar correlation results, but the O3-only exposure demonstrated significant positive 
correlations with the lung function measurements. Isolation of the individual exposure results 
showed that the DE particulate (and potentially more of the components of the DE) were not 
directly related to lung function, but were correlated with decreases in blood pressure.  This 
discovery was important for the interpretation of the co-exposure results because the addition of 
the O3 showed that the biological mechanism that created the lung function changes was either 
more closely related to another biological pathway, or the biological sampling methodology was 
not specific enough to address the time-dependent perfusion of the cytokines into the peripheral 
blood.  Few studies have been successful in finding correlations between plasma biomarkers and 
O3-induced lung function decrements, and those that were demonstrated lipid-associated 
correlations but not protein-associated correlations (Schlegle et al. 1989).     
 We were also interested to find, for the first time, the negative correlations between 
systolic blood pressure and both IL-8 and IFN-γ following the DE+O3 exposure.  Our initial 
assumptions, given the results from Chapter 3, were that the post-exposure decrease in IFN-γ 
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would have a positive correlation with the post-exposure decrease in blood pressure and there 
was no a priori hypotheses related to IL-8 since it did not exhibit a change following any of the 
three exposures.  We summarized these results by suggesting that these two Th1 cytokines were 
facilitating this decrease in the SBP.  
The third, and potentially most important, outcome from Chapter 4 was demonstrated by 
the estimated intraclass correlation coefficients.  We assumed that the individuals in the groups 
would respond in the same way to the respective exposures.  Our results suggested that there is a 
lot of variation in response across the individuals and that the exposure-response effect was 
solely dependent on the individual.  We investigated potential causes of this variation in response 
(gender, BMI, and GSTM1 status), but did not have enough statistical power due to the size of 
our groupings.  Figure 5.1, below, illustrates the diversity of the individual responses that were 
encountered after interpretation of the estimated ICCs.  Participants 1 and 2 show essentially no 
response at all whereas participants 3 and 4 have a large (greater than 25%) decrease in FEV1 
following the exposures. 
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Figure 5.1: Differential Lung Function Results for Four Individual Participants Following 
DE+O3 Co-exposure 
 
The initial statistical analysis showed that there was a statistically significant decrease in 
FEV1 following the DE+O3 exposure, but the individual level results show vastly different 
responses.  Here, we use FEV1 as an example, but the cytokines also displayed this type of 
individual variance in response following the DE+O3 exposure.  This response is important to 
note because the participants in this study were healthy and were relatively the same when 
compared to the rest of the US population.  Demonstrating the variance in the individual results 
for healthy adults shows that susceptible individuals are not readily identified with standard 
screening tests and could potentially have more extreme responses.  These results also point 
toward the need for further investigation into the underlying characteristics that contribute to this 
variance.   
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5.4 Limitations 
 One of the initial goals for this research was to investigate how metadata played a role in 
the exposure-response relationships.  Specifically, we wanted to examine differential responses 
by gender, BMI, and GSTM1 status following the three exposures.  There is a wealth of 
scientific literature demonstrating variation in response to environmental exposures based on 
demographic data, and we wanted to use this type of data to elucidate any underlying differences 
in response using these three classifications (Alexis et al., 2009; Gilliland et al., 2002; Setlow et 
al., 1998).  Unfortunately, there was not sufficient statistical power to differentiate responses 
based on gender or BMI.  The results in Chapter 4 come close to demonstrating statistically 
significant differences for the cytokine responses and the blood pressure measurements based on 
GSTM1 status, but the analysis was limited by the number of GSTM1- volunteers.   
The cytokine results for this dissertation came from circulating blood and not from 
pulmonary or upper airway tissue.  Samples collected in these locations would presumably have 
given a more direct relationship between the inhalation exposures and the inflammatory 
response.  Exhaled breath condensate samples were collected and analyzed for the cytokines of 
interest as a substitute for tissue samples, but describing these exposure-response relationships is 
an area for future research. 
 
5.5 Future Work 
 The work presented in Chapters 3 and 4 is focused on the relationship between the three 
exposures and cytokines in blood plasma.  We demonstrated that the method was robust enough 
to use on human plasma, exhaled breath condensate, and urine.  Knowing this, the EBC and 
urine samples from DEPOZ were analyzed for the 10 cytokines.  Determining the exposure-
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response relationships for these two additional biological media could offer a more complete 
explanation of the “total” biological response following the respective exposures.   
This work was also primarily focused on the results from “Day 1” of the respective 
exposures.  As described in the study design, the first day of the exposure was always followed 
by on the next day by an O3 exposure.  One purpose of this design was to investigate if the first 
day's exposure could be a "primer" for a more adverse response to a secondary exposure, 
essentially mimicking a real life exposure on two consecutive days.  As such, the samples for 
these days need to be investigated to see if any of the prior day’s exposures could “pre-dispose” 
a person to have a greater inflammatory reaction following the O3 exposure on day 2. 
 
5.6 Conclusions 
In conclusion, the research presented in the dissertation has added to the exposure 
assessment field with several unique contributions.  An immunochemistry method with certain 
improvements in raw signal interpretation has been shown to be sensitive and specific enough to 
investigate inflammatory markers in three different human biological media from “healthy” 
people.  Second, the results demonstrate that specific cytokines respond following DE-only and 
O3-only exposures, and that a synergistic exposure-response relationship is created when 
combining DE and O3 into a mixed exposure.  Next, the results have described and created a link 
between the three exposures, inflammatory markers, and cardiovascular health effects.  The 
results also demonstrate that individuals have independent responses following exposure and that 
discounting this fact could lead to a miss-interpretation of the exposure-response relationship 
between the three exposure and the inflammatory response.  Finally, I hope that the results from 
this dissertation and subsequent publications will be used in future risk analyses and decisions to 
help alleviate the overall burden of ambient-acquired cardiovascular disease. 
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